Bioluminescent calcium indicator protein and gold nanoparticle-enhanced bioluminescence by Wang, Zuhui













Presented to  













In Partial Fulfillment for the Degree 
















Copyright © 2018 by Zuhui Wang 




















Dr. Robert E. Gross, Advisor 
Department of Neurosurgery 
Emory University 
 
Dr. Lily S. Cheung 
Department of Chemical and Biomolecular Engineering 
Georgia Institute of Technology 
 
Dr. Kostas Konstantinidis 
School of Civil and Environmental Engineering 
Georgia Institute of Technology 
 
 







I would first like to thank my thesis advisor Dr. Robert Gross for giving me the 
opportunity and resources of studying molecular biotechnology in his laboratory to 
complete my master’s degree.  
I would also like to thank Dr. Ken Berglund, Assistant Professor in the Dr. Gross’s 
lab. Ken was my experimental teacher, who was always there for help. He 
consistently allowed this paper to be my own work and steered me in the right 
direction. 
I would also like to give special thanks to my parents. Without your support, I could 










ACKNOWLEGMENTS .............................................................................................. iii 
 
LIST OF TABLES ........................................................................................................ vi 
 
LIST OF FIGURES .................................................................................................... vii 
 
LIST OF ABBREVIATIONS ....................................................................................... ix 
 
SUMMARY ................................................................................................................... x 
 
Chapter 1 INTRODUCTION ......................................................................................... 1 
1.1 Motivation ................................................................................................................ 1 
1.2 Research Objectives ................................................................................................. 3 
 
Chapter 2 LITERATURE REVIEW .............................................................................. 6 
2.1 General Characteristics of Ca2+ Indicator ................................................................ 6 
2.1.1 Ca2+ Affinities ........................................................................................... 7 
2.1.2 Spectral Properties .................................................................................. 10 
2.1.3 Indicator Forms ....................................................................................... 11 
2.2 Chemically Synthesized Ca2+ Indicator ................................................................. 12 
2.3 Genetically Encoded Ca2+ Indicator ...................................................................... 13 
2.3.1 Ca2+ binding protein motifs .................................................................... 13 
2.3.2 FRET-based GECIs ................................................................................ 15 
2.3.3 Single fluorophore-based GECIs ............................................................ 19 
2.4 Localized Surface Plasmon Resonance (LSPR) .................................................... 21 
2.5 Gold Nanoparticle (AuNP) and Protein Conjugation ............................................ 23 
2.5.1 AuNP size ............................................................................................... 24 
2.5.2 Hydrophobicity ....................................................................................... 24 
2.5.3 Surface chemistry.................................................................................... 25 
 
Chapter 3 Ultrasensitive Bioluminescent Calcium Indicator Protein .......................... 26 
3.1 Introduction ............................................................................................................ 26 
3.2 Methodology .......................................................................................................... 29 
3.2.1 Plasmid Design ....................................................................................... 29 
3.2.2 Bioluminescent Intracellular Ca2+ Response in HEK293 Cells .............. 30 
3.2.3 Fluorescent Intracellular Ca2+ Response in HEK293 Cells .................... 32 
3.3 Results and Discussion .......................................................................................... 34 
3.3.1 Structure-based Design of the Ca2+ Indicators ........................................ 34 
3.3.2 Intracellular Ca2+ Response in HEK293 Cells ........................................ 35 




Chapter 4 Gold Nanoparticle Enhanced Bioluminescence .......................................... 42 
4.1 Introduction ............................................................................................................ 42 
4.1.1 Introduction of luminopsin ..................................................................... 42 
4.1.2 Ni-NTA-Au conjugation with histidine .................................................. 43 
4.2 Methodology .......................................................................................................... 45 
4.2.1 Plasmid Design ....................................................................................... 45 
4.2.2 In vitro AuNP bioluminescence enhancement ........................................ 46 
4.3 Results and Discussion .......................................................................................... 48 
4.3.1 Structure of his-tagged GLuc(LMO) ...................................................... 48 
4.3.2 In vitro Ni-NTA-Au Bioluminescence Enhancement in HEK293 cells . 48 
4.3.3 Evaluation of the Performance ................................................................ 53 
 
Chapter 5 Conclusion of the Thesis ............................................................................. 55 
 









Table 1 High affinity chemically synthesized Ca2+ sensors ........................................ 12 
Table 2 Comparison of Biochemical Properties of Purified GCaMP series sensors. .. 20 
Table 3 Biophysical properties of Ca2+ indicators in HEK293 Cells .......................... 39 








Figure 2-1 Excitation spectrum of Fura-2 dye measured at emission wavelength of 
510 nm with free Ca2+ from 0 – 39.8 μΜ.. .................................................................. 11 
Figure 2-2 Structure of typical EF-hands and its Ca2+ binding center. ........................ 14 
Figure 2-3 Schematic of the Ca2+ coordination in a canonical EF-hand. .................... 15 
Figure 2-4 Dependency of FRET efficiency (EFRET) on the distance (r) between a 
donor-acceptor pair with an assumed Förster radius R0 of 50 Å. ................................ 16 
Figure 2-5 Calmodulin (CaM)/FRET-based GECIs. ................................................... 17 
Figure 2-6 Circular permutation of GFPs. ................................................................... 19 
Figure 2-7 Schematic representation of GCaMP and its crystal structure. .................. 20 
Figure 2-8 Schematic diagrams illustrating (A) a surface plasmon polariton (or 
propagating plasmon) and (B) a localized surface plasmon. ....................................... 23 
Figure 3-1 Schematic representation of sbGLuc and GCaMP6s based Ca2+ indicators 
and corresponding 2A negative control. ...................................................................... 28 
Figure 3-2 Schematic representation of the mechanism of “self-cleaving” 2A peptides..
...................................................................................................................................... 29 
Figure 3-3 Simplified amino acid sequences of GCaMPGLuc, GLucGCaMP and 
GCaMP2AGLuc. Specifically, 2A in GCaMP2AGLuc is T2A peptide. .................... 30 
Figure 3-4 Plate arrangement of transfection and free Ca2+ calibration.. .................... 31 
Figure 3-5 Workflow of the image analysis. ............................................................... 33 
Figure 3-6 Crystal structure of GCaMP6m from the top view .................................... 35 
Figure 3-7 In vitro Ca2+ titration by BRET.. ................................................................ 36 
Figure 3-8 Donor-acceptor energy transfer.................................................................. 37 
Figure 3-9 In vitro Ca2+ titration by fluorescence. ....................................................... 38 
Table 3 Biophysical properties of Ca2+ indicators in HEK293 Cells .......................... 39 
Figure 3-10 Emission ratio of GCaMPGLuc and GLucGCaMP on two dates separated 
six months exhibits consistent response.. .................................................................... 41 
Figure 4-1 Schematic representation of Ni-NTA-Au binding with histidine and its 
structure........................................................................................................................ 43 




Figure 4-3 Schematic sequence structure of the original eLMO3 (GLuc(LMO)) and 
designed three his-tagged eLMO3. .............................................................................. 45 
Figure 4-4 Nhis_GLuc(LMO), NChis_GLuc(LMO), Chis_GLuc(LMO) and 
GLuc(LMO) expression in HEK293 cells.. ................................................................. 49 
Figure 4-5 Total light yield of the four GLuc(LMO)s.. ............................................... 49 
Figure 4-6 Enhancement factor of Nhis_GLuc(LMO), NChis_GLuc(LMO), Chis_ 
GLuc(LMO) and GLuc(LMO), after incubating with 0.5 nM of various size of AuNPs.
...................................................................................................................................... 51 
Figure 4-7 Enhancement factors of  Nhis_GLuc(LMO), NChis_GLuc(LMO), 
Chis_GLuc(LMO) and GLuc(LMO) after incubating with 0.5, 1 and 5 nM of Ni-
NTA-Au and simple Au (both d = 10 nm)………………………………………….. 53 
   
ix 
 




AuNP: Gold nanoparticle, 
BRET: Bioluminescence resonance energy transfer, 
CaM: Calmodulin, 
cpEGFP: Circularly permutated enhanced green fluorescent protein, 
FRET: Förster resonance energy transfer, 
GECI: Genetically encoded calcium indicator, 
GLuc: Gaussia luciferase, 
LMO: Luminopsin, 
LSPR: Localized surface plasmon resonance, 
sbGLuc: “Slow-burn" Gaussia luciferase", 
SPR: Surface plasmon resonance, 
TnC: Troponin C, 





Bioluminescent proteins have been extensively used as a light emission source for 
many fusion proteins and have a wide range of applications in imaging and cell 
signaling studies. In this study, the smallest known luciferase from the marine 
copepod, Gaussia princeps, was used to engineer novel bioluminescent sensors and 
novel methods to enhance bioluminescence intensity. In the First part of the study, 
two bioluminescent calcium sensors were developed, which were composed of a 
variant of Gaussia luciferase (sbGLuc) and the fluorescent calcium indicator protein, 
GCaMP6s. The two designs allowed bioluminescence resonance energy transfer 
(BRET) and they exhibited excellent dynamic range. In the Second part of the study, 
several strategies to enhance bioluminescence by conjugating sbGLuc with gold 
nanoparticles were carefully examined. On average, 26% enhancement on 
bioluminescence was achieved. The new sensors together with the gold nanoparticle-
enhanced bioluminescence should be useful for various studies in various fields such 
as neuroscience and cell biology. 
1 
 
CHAPTER 1 INTRODUCTION 
1.1 Motivation 
Bioluminescence, which is luciferase-catalyzed light-emitting reactions of molecular 
oxygen with its substrate luciferin, provides a potent biomolecular toolbox to study 
cell biology. One promising application of bioluminescence is designing robust and 
sensitive biosensors to monitor and further manipulate various cell activities. In living 
cells, Ca2+ is a crucial signaling ion that is poised at the core of a sophisticated 
network of signaling pathways (Dodd, Kudla, & Sanders, 2010). These pathways 
integrate information from biotic and abiotic stimuli to intricately control gene 
expression. Intracellular Ca2+ is central to a multitude of physiological processes 
ranging from bone formation to muscle contraction to neuronal signaling and 
exocytosis (Berridge, 1993). Abnormal Ca2+ signaling transduction will lead to severe 
pathological consequences such as skin disorders, heart disease, skeletal muscle 
defects, neurodegeneration, disorders of the central nervous system (Carafoli, 2004). 
Thus, great interest arises to monitor intracellular Ca2+ concentration [Ca2+] in real 
time. Intracellular [Ca2+] takes the form of free Ca2+, or more precisely, the activity of 
cytosolic free Ca2+, [Ca2+]i. In neurons, [Ca
2+]i is maintained around 100 nM, 
variously reported as 20,000 to 100,000-fold lower than typical extracellular 
concentration so that Ca2+ can work as a critical intracellular signal in various 
processes.  
All those characteristics of intracellular free Ca2+ require that live cell Ca2+ 
measurements possess ultra-sensitivity, stability and non-cytotoxicity. So far, 
fluorescence-based Ca2+ indicators are the only successful approach to track real-time 
intracellular Ca2+ in cellular processes (M. Mank & Griesbeck, 2008). Whether there 
are chemically synthesized fluorescence dye or genetically encoded Ca2+ indicators 
(GECIs), they work on the changes of the fluorescence signal, which requires external 
light to excite fluorophore. Such approaches require implantation of fiber optics for in 
vivo excitation, which may impair the results accuracy due to improper installation or 
even tissue damage. Long term monitoring and control also are challenging due to 
potential photobleaching of fluorophore and phototoxicity by using intensive 
excitation light. Thus, developing a robust sensitive genetically encoded Ca2+ 
indicator without the need of external excitation light is strongly desired, which could 
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be achieved through coupling traditional fluorescence based GECIs with 
bioluminescence. 
Besides monitoring cell activities, bioluminescence can coordinate with other light-
sensitive channel proteins (e.g. channelrhodopsins, proton or chloride pumps) to 
manipulate cell (especially neuron) activities, which further developed into 
optogenetics techniques. The efficiency of optogenetic probes heavily depend on 
spectral properties of luciferase, such as intensity, peak wavelength, kinetics, etc.  
Compared with extensively studied firefly luciferase (FLuc) from Photinus pyralis 
and Renilla luciferase (RLuc) from Renilla reniformis, more recently discovered 
Gaussia luciferase (GLuc) from the marine copepod Gaussia princeps has been 
shown to give much brighter bioluminescence than either FLuc or RLuc (Goerke, 
Loening, Gambhir, & Swartz, 2008; Tannous, Kim, Fernandez, Weissleder, & 
Breakefield, 2005). However, native GLuc has burst kinetics with a half-life of 
around 1 min and still dim bioluminescence intensity, limiting the applications in long 
time scale detection (Aslan & Geddes, 2009; Karolin & Geddes, 2012). Welsh and 
Patel (2009) obtained a series of mutated GLuc by the point mutations of methionines 
to leucines, among which M43L and M110L mutation (named as “slow-burn” GLuc 
or sbGLuc) provided prolonged light emission with a half-life of around 14 min while 
preserving much of the bioluminescent intensity. Thus, if the bioluminescent intensity 
of sbGLuc is further enhanced with a simple strategy, it should be a useful approach 
to ameliorate the performance of bioluminescence based optogenetic probes, such as 
luminopsin. LMO3 luminopsin (luciferase + opsin) is an optogenetic probe based on 
the fusion protein of sbGLuc with Volvox channelrhodopsin 1 (VChR1) developed in 
our lab (Berglund et al., 2016). If the bioluminescence intensity of sbGLuc gets 
enhanced, VChR1 could be more activated to generate stronger depolarization upon 
application of the same amount of coelenterazine (CTZ), a substrate for GLuc. By 
coupling localized surface plasmon with excitation-state molecules via non-
radioactive energy transfer (also known as localized surface plasmon resonance, 
LSPR), Au nanocrystals are demonstrated to enhance bioluminescence of horseradish 
peroxidase (HRP) nanoclusters (Du, 2014). Thus, LSPR provides a promising 




1.2 Research Objectives 
The overall objective of this research was first to develop genetically encoded Ca2+ 
indicators (GECIs) that can operate by noninvasive bioluminescent excitation while 
preserving fluorescence excitability; and second to develop a novel bioluminescence 
enhancement strategy of coupling gold nanoparticles with sbGLuc. This research was 
performed through two specific aims as outlined below: 
1. Evaluate the Ca2+ binding properties of proposed GECIs under 
bioluminescence excitation and fluorescence excitation separately in 
HEK293 cells. 
Ca2+ affinity and dynamic range are crucial parameters when describing Ca2+ 
binding properties of a given GECI. The dissociation constant (Kd) describes 
how tightly an indicator binds Ca2+ ions, and apparent Kd is more frequently 
reported when the binding process is cooperative. Previous studies (Nakai, 
2001) have shown that calmodulin cooperatively binds with Ca2+ ions, which 
can be depicted by the Hill equation. Therefore, we aimed to characterize the 
bioluminescence-fluorescence signal change of our GECIs under calibrated 
intracellular gradient of [Ca2+] in HEK293 cells. Subsequently, the regression 
of signal changes with the Hill equation can provide apparent Kd and Hill 
coefficient of each variant of GECIs. Together with the dynamic range of 
signal changes, we can systematically evaluate the performance of our new 
GECIs under bioluminescence and fluorescence working conditions, which 
lays the foundations for future in vivo applications.  
2. Provide experimental evidence of proposed GECIs working mechanism. 
Our proposed GECIs should work by bioluminescence resonance energy 
transfer (BRET) when using bioluminescence as light sources. BRET follows 
the same physical rules as Förster resonance energy transfer (FRET). Thus, 
solid experimental evidence should be provided to support this mechanism. 
3. Evaluate the bioluminescence enhancement of coordinating Au nano-
particles with sbGLuc of luminopsin on HEK293 cell membrane and 
determine the best working conditions (i.e. size and concentration of Au 
nanoparticles, and conjugation strategy). 
LSPR can both enhance absorption and scattering of incident light, whereas 
only scattering can amplify the overall emission intensity. The ratio of 
scattering versus absorption in LSPR mainly depends on the size, shape, & 
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surface chemistry of Au nanoparticles, the dielectric constant of the medium 
environment, and the distance of an Au nanoparticle’s surface to luciferase. 
LSPR of Au nanoparticles has been shown to be able to enhance 
bioluminescence of purified luciferase clusters, but Au nanoparticles have 
seldom been conjugated with luciferase expressed on the cell surface (e.g. the 
luciferase moiety of luminopsin). In order to obtain the best working 
conditions of our proposed Ni-NTA-Au conjugation strategy, the 
bioluminescence enhancement must be analyzed under various Au sizes, Au 
concentrations, and Au surface chemistry individually with proper control in 
vitro.  
To date, no studies have attempted to provide GECIs that can function under both 
bioluminescence and fluorescence excitation. Since bioluminescence of GLuc only 
requires its cell membrane- and blood brain barrier-permeable substrate 
coelenterazine (CTZ), the working process of GECIs based on bioluminescence is 
less invasive in vivo, compared with other fluorescence based GECIs, which always 
require installation of optical fibers or exposure of the brain tissue to strong excitation 
light delivery. Also, because our GECIs are ratiometric indicators based on the ratio 
of peak wavelength of donor and acceptor domain, they yield more accurate and 
repeatable results that are independent of optical pathways and CTZ concentrations. 
Those parameters are practically hard to control in vivo.  
Meanwhile, dim bioluminescence intensity is one restriction that limits sensitivity of 
many bioluminescence-based biosensors. Au nanoparticles have recently shown great 
potential in bioluminescence enhancement (Du et al., 2014). Thus, developing a 
simple and effective bioluminescence enhancement strategy using Au nanoparticles is 
strongly desirable.  
The significance of the first part of this work stems from the persistent demand of 
accurate, sensitive, and noninvasive Ca2+ biosensors in cell biology studies. Ca2+ 
signaling cascade is a critical signal pathway in bone formation, muscle contraction, 
exocytosis, neuronal signaling, etc. Our bioluminescence based GECIs provide a 
novel tool for studying intracellular Ca2+ dynamics where target tissue is extremely 
fragile such as brain tissue. The significance of the second part of this work stems 
from the strong desire to improve bioluminescence intensity, where the sensitivity and 
activity of bioluminescent biosensors are restricted by dim bioluminescence. By 
exploiting LSPR of Au nanoparticle on bioluminescence enhancement, 
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bioluminescence should be more competitive in developing more sensitive and 
effective biosensors. 
In the chapters that follow, a comprehensive background of my work was provided. In 
chapter 3, two BRET based GECIs were proposed. Then, the design of the two BRET 
based GECIs was fully detailed, and in vitro experiments were performed to test my 
design. At the end of this chapter, the results of the experiments were reported and 
discussed. The directions for future studies were suggested as well. 
In chapter 4, the enhancement of bioluminescence of sbGLuc by gold nanoparticles 
(AuNPs) was presented. A strategy of conjugating hexahistidine tagged lumiopsins 
(LMOs) with Ni-NTA-Au complex to leverage LSPR on Au surface to enhance 
bioluminescence on cell surfaces was proposed. Then, the design of three his-tagged 
LMOs was fully detailed, and in vitro experiments to test their performance were 
performed. At the end of this chapter, the results of the experiments were reported and 
discussed, and the direction for future studies was suggested. In the last chapter, the 




CHAPTER 2 LITERATURE REVIEW 
2.1 General Characteristics of Ca2+ Indicator 
Generally speaking, Ca2+ indicators exhibit altered fluorescent properties that depend 
on Ca2+ binding. Based on their chemical origin, Ca2+ indicators can be categorized 
into two classes: chemically synthesized indicators and genetically encoded indicators. 
An important thing to note is that Ca2+ indicators bind and interact only with free Ca2+ 
ions. In this light, the majority of intracellular Ca2+ is not free to diffuse but tightly 
chelated with various cytosolic buffers. The equilibrium of bound Ca2+ and free Ca2+ 
varies in different cell types as well as in various compartments of a cell. Roughly 
speaking, in every 100 cytosolic Ca2+ ions, only 1 Ca2+ ion is free to diffuse. This 
ratio is of the order of 10 to 1 within the endoplasmic reticulum (Li & Camacho, 2004; 
Raeymaekers, 1998). Since Ca2+ indicator itself also chelates Ca2+, it can impact both 
the levels and most noticeably, the kinetics of Ca2+ signaling within cells. Thus, users 
have to carefully consider not only the spectral characteristics of a chemical indicator 
(e.g. whether it fluoresces in the red or green spectrum), but also pay close attention 
to its Ca2+ binding properties (Paredes, Etzler, Watts, Zheng, & Lechleiter, 2008). 
In order to choose the most appropriate Ca2+ indicator to fit your study needs, there 
are several aspects that need to be considered, detailed in Paredes et al. (2008)’s 
review. Here are some major concerns which will be discussed below. First, users 
need to choose indicators with appropriate Ca2+ affinities. Since the Ca2+ indicator 
itself can bind with free Ca2+ that could significantly affect Ca2+ signaling. Therefore 
users must balance the trade-off of increasing the strength of the indicator signal with 
increasing concentration and affinities of indicators. In some cases, indicators with 
low Ca2+ affinities are required to reduce the impact of buffering of the indicator itself, 
but this also pays the cost of signal strength. Second, spectral properties of indicators 
need to be considered, as ratiometric and intentiometric indicators have their own 
strengths and weaknesses. Third, specifically for synthetic Ca2+ indicators (dyes), 
users need to choose the proper form of the dyes, since it decides the following 
loading procedures. These criteria are generally applicable for both synthetic 
Ca2+ indicators and genetically encoded Ca2+ indicators. 
7 
 
2.1.1 Ca2+ Affinities 
Chemically speaking, Ca2+ affinities of indicators can be depicted by classical ligand-
macromolecule interaction model mathematically. Let I stand for the indicator with x 
binding sites of free Ca2+, and L stands for the ligand free Ca2+ ion, as shown in 
equation 2-1. Such ligand-macromolecule saturation process can be depicted by the 
Hill equation (equation 2-2), where θ is the fraction of the indicator concentration that 
is bound to Ca2+. The apparent dissociation constant (Kd), as defined in the equation 
2-3, describes how tightly an indicator binds free Ca2+ ions. The hill coefficient n 
describes cooperativity of the binding process, of which is normally bigger than 1 for 
Ca2+- calmodulin interaction (Chen et al., 2013). The binding process with >1 hill 
coefficient is called positive cooperative binding, of which one ligand molecule 
bound to the enzyme facilitate following ligand binding to other sites. It is worth to 
note that the hill coefficient n rarely equals the number of binding sites x on 
macromolecules, instead can be interpreted as an “interaction coefficient” describing 
the cooperativity among ligand binding sites. From definition of Kd, it has molarity 
units (M) and equals the ratio of ka (forward rate, or the rate of association of the 
indicator-Ca2+ complex) and kd (reverse rate, or the complex's rate of dissociation). 
KA is equal to the concentration of free Ca
2+ at which half of the total indicator 
molecules are bound with Ca2+, which also called microscopic dissociation constant. 
Hence, since the hill coefficient n for Ca2+-calmodulin binding >1, the lower Kd is, the 
less Ca2+ affinity the indicator has, and the more sensitive the indicator is. When 
possible, users should choose the indicators that targeting [Ca2+] to be measured is 
between 0.1 to 10 times their Kd
 (Paredes et al., 2008), because within this range, 
fluorescence changes of indicators are the largest. If Kd is too far away from [Ca
2+] of 
working environment, GECIs will be either saturated or unbound, which leads to no 
signal response to [Ca2+] change. 

















                             eq. 2-2 







n                                  eq. 2-3 
It is important to note that Kd is also dependent on pH, temperature, viscosity, ionic 
strength, protein binding and the amount of Mg2+ and other ions present (Larsson, 
Larsson, Lundgren, & Sundell, 1999; Lattanzio, 1990; Oliver, Baker, Fugate, Tablin, 
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& Crowe, 2000; Woodruff et al., 2002). As the result, the Kd of certain indicator in 
vivo may not have the same value as the Kd in vitro. It may be even different at each 
subcellular compartment in the same cell type. Thus, to obtain accurate calibration 
result, it is necessary to measure Kd in situ each time ahead of the actual measurement. 
Most commonly, Ca2+ indicators will exhibit different emission spectrum under a 
series of equilibrated buffer with gradient [Ca2+] up to the indicator saturation. For 
single wavelength based Ca2+ indicators (see 2.1.2), their fluorescence emission at 
single wavelength F can be normalized to θ by (F-Fmin)/(Fmax-Fmin), where Fmax 
and Fmin is the fluorescence emission at two [Ca2+] boundaries in calibration buffer, 
and fitted with the Hill equation (eq. 2-2) to obtain Kd and n. The Kd obtained in this 
way is the apparent dissociation constant, which is specific for the current emission 
wavelength. For ratiometric Ca2+ indicators, if we use similar strategy to normalize 
the ratio R of two wavelengths with θ = (R-Rmin)/(Rmax-Rmin) and fit into the Hill 
equation (eq. 2-2), the apparent Kd obtained is only comparable with other ratiometric 
Ca2+ indicators using the ratio of the same wavelengths. If a single wavelength Ca2+ 
indicator shares one same emission wavelength with a ratiometric Ca2+ indicator, the 
apparent Kd obtained above cannot be directly compared between the ratiometric and 
the single wavelength Ca2+ indicator, since the apparently Kd  contains the systematic 
bias from that different emission wavelength. Grynkiewicz, Poenie, and Tsien (1985) 
derived a calibration equation of ratiometric indicators with Hill coefficient 1, which 
form a simple 1:1 complex with Ca2+, assuming the indicator concentration and path 
length are small enough for the fluorescence contribution from any given molecular 
species to be proportional to the concentration of that species, which is generally true 
in most physiological conditions (Grynkiewicz et al., 1985). The Kd calculated from 
their equation is corrected to reflect the Ca2+ affinities under only one wavelength, 
which can be then compared with single wavelength Ca2+ indicator sharing the same 
emission wavelength, thus called the effective Kd. Here I will generalize this equation 
for indicators with any Hill coefficient n.   
Using the same notation as in Grynkiewicz et al. (1985), two wavelengths and two 
species (free and Ca2+ bound indicators, simplified as indicators below) require four 
proportional coefficients, hereby symbolized as Sf1 for free indicators measured at 
wavelength λ1, Sf2 for free indicators at λ2, Sb1 for Ca
2+ bound indicators at λ1, Sb2 for 
Ca2+ bound indicators at λ2. Under the assumption of proportional relation between 
the species concentration and their emission intensities, 
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𝐹1 = 𝑆𝑓1𝑐𝑓 + 𝑆𝑏1𝑐𝑏 (1) 
𝐹2 = 𝑆𝑓2𝑐𝑓 + 𝑆𝑏2𝑐𝑏 (2) 
where F1 is the sum of the fluorescence emission contributed by the concentration cf 
of free indicators at wavelength λ1 and the fluorescence emission contributed by the 
concentration cb of bound indicators at λ1, so do the similar definition for F2 at 
wavelength λ2.  













rearrange to get 






which is applicable to indicators with any Hill coefficient n. 







  (5) 













Note that 𝑆𝑓1/𝑆𝑓2 is simply the limiting value that R can have at zero [Ca
2+] and so 
may be approximate as Rmin, while 𝑆𝑏1/𝑆𝑏2is the analogous limiting Rmax that the 
ratio has at saturating [Ca2+]. The above equation can be further converted to the 







)] = 𝑛𝑙𝑜𝑔[𝐶𝑎2+] − 𝑛𝑙𝑜𝑔𝐾𝑑 (7) 




on Kd caused by emission wavelength λ2 compared with the apparent Kd directly 
derived from the Hill equation containing the influence from  
𝑆𝑓2
𝑆𝑏2





)] = 𝑛𝑙𝑜𝑔[𝐶𝑎2+] − 𝑙𝑜𝑔𝐾𝑑   (8) 
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Thus, the effective Kd of ratiometric indicators derived from (7) is comparable with 
the apparent Kd of single wavelength indicators derived from (8), where they share 
the same emission wavelength λ1. 
2.1.2 Spectral Properties 
Since all available Ca2+ indicators are based on fluorescence changes upon Ca2+ 
binding, the spectrum changes determine the final results and should be carefully 
considered. Generally, Ca2+ indicators can be categorized either single-wavelength 
(intentiometric) or double-wavelength (ratiometric) indicators. Single wavelength 
indicators exhibit significant Ca2+ dependent changes in fluorescence intensity 
without shifting their relative excitation or emission spectrum (e.g. Figure 2-1). It is 
easier to avoid or minimize spectral overlap with other fluorophores when working 
with single wavelength indicators (Peter Lipp, Lüscher, & Niggli, 1996; P Lipp & 
Niggli, 1993; Nicotera & Rossi, 1994). However, for chemically synthesized 
indicators, the measuring variable is also affected by experimental procedures like 
uneven dye loading, dye leakage, photobleaching and changes in cell volume; for 
genetically encoded indicators, the measuring variable is affected by handling cell 
types, transfected cell numbers, expression levels, etc. Another class, ratiometric 
indicators shift the peak wavelength of either their excitation or emission spectrum 
upon binding Ca2+. This class of indicators permit more accurate quantification of the 
free [Ca2+] compared with single wavelength indicators, because the measuring 
variable is unitless that only depends on the free [Ca2+].  
Imaging equipment is another major consideration when choosing proper indicators. 
Obviously, kinds of indicators are limited by the corresponding excitation light 
sources. For single-photon laser scanning microscopes (1p-LSM), the excitation of 
indicators needs to match with the specific available lasers. When working with two-
photon laser scanning microscopes (2p-LSM), the absorption properties of Ca2+ 
indicators can be significantly different than what might be predicted by simply 
doubling the peak of single photon absorption wavelength. Additional absorption 
peaks are frequently present at shorter wavelengths. Absorption curves can also be 
much broader for two-photon excitation, making it more difficult to exclusively excite 
an indicator at a single wavelength. 
For conventional widefield epi-fluorescent microscope, the excitation of indicators is 
limited by the appropriate and specific filter set. If a widefield epifluorescence 
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microscope is used, the light source may also affect the performance of the indicators. 
The two most common lamp sources used in widefield epifluorescence microscopes 
are the mercury and xenon arc burners. Both are broad-spectrum emitters. However, 
mercury lamps do not provide an even intensity across the entire spectrum. The 
highest intensity peaks occur at 334, 365, 406, 435, 546 and 578 nm with steady 
lower intensity at wavelengths in between these values (Paredes et al., 2008). Xenon 
lamps have a relatively even intensity across the visible spectrum, but they are not as 
intense and are particularly lower in the ultraviolet. 
Finally, auto-fluorescence comes from biomolecules (e.g. NAD(P)H and flavin) and 
materials to hold the fluorescent specimen (e.g. plastic cultureware) must be 
distinguished and subtracted from indicators fluorescence signal. When signal-to-
noise ratio is high, e.g. background signal is less than 10% of total signal, after 
subtracting the background signal, measuring variable can keep good dependency 
with free [Ca2+]. However, when background signal is too high, e.g. higher than 80% 
of total signal, even after subtracting the background, the measuring variable may lose 
dependency on free [Ca2+].  
 
 
Figure 2-1 Excitation spectrum of Fura-2 dye measured at emission wavelength of 
510 nm with free Ca2+ from 0 – 39.8 μΜ. Two excitation peaks were seen around 340 
nm and 380 nm wavelength. The excitation peak for 340nm increases with increase in 
[Ca2+] whereas the excitation peak for 380nm decreases with increase in the [Ca2+]. 
 
2.1.3 Indicator Forms  
Chemical forms of Ca2+ indicators are the concerns of chemically synthesized Ca2+ 
indicators, since different forms will directly affect the loading procedures, targeting 
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efficiency and possible compartmentalization. Generally, there are three common 
chemical forms that are available commercially: salts, dextran conjugates or 
acetoxymethyl (AM) esters. More detailed discussion can be found in Paredes et al. 
(2008)’s review. One major advantage of genetically encoded Ca2+ indicators are that 
they can be specifically targeted to interested subcellular site by noninvasive means 
like cell-type specific promoters, cellular targeting sequences, transgenic technology, 
etc (Akerboom et al., 2013; Marco Mank et al., 2008; Tian et al., 2009). 
2.2 Chemically Synthesized Ca2+ Indicator 
The measurement of intracellular [Ca2+] first became practical and common after 
chemically synthesized Ca2+ indicators (or commonly called dyes) were developed. 
Thanks for the work of Roger Y. Tsien, who generated a series of fluorescent 
polycarboxylate compounds with strongly improved fluorescence properties. 
Nowadays, there are a broad range of Ca2+ affinities that are commercially available 
for the users, and protocols of utilizing these dyes in vivo and in vitro are well 
established (Rehberg, Lepier, Solchenberger, Osten, & Blum, 2008). Here I tabulate 
some common commercial dyes with high sensitivity (high affinities) in Table 1. 
 







Calcium Green-1  190 490 ex, 531em Single wavelength 
Fluo-3 325 506 ex, 526 em Single wavelength 
Fluo-4 345 494 ex, 516 em Single wavelength 
Fura-2 145 363&335 ex, 512 em Dual excitation/single 
emission 
Indo-1 230 488 ex, 405&485 em Single excitation/dual 
emission 
Oregon Green 488 
BAPTA-1 





Table 1 (continued). 










185 590 ex, 615 em Single long wavelength 
X-rhod-1 0.7 580 ex, 602 em Single excitation/emission 
 
2.3 Genetically Encoded Ca2+ Indicator 
Since synthesized Ca2+ indicators face great difficulty in dye loading process, 
controllable compartmentalization and diffusion and specific labeling at subcellular 
level like pre- or postsynaptic sites, genetically encoded Ca2+ indicators (GECIs) are 
proposed to address these problems. So far, the fluorescence of known native 
fluorescent proteins (XFPs, e.g. GFP) is in general insensitive to fluctuation of [Ca2+]. 
To confer XFPs Ca2+ sensitivity, GECIs fuse Ca2+ binding protein motifs and XFPs 
with their mutants to translate Ca2+ signal to light signal and detect by imaging 
devices. There are two successful paradigms of constructing GECIs: FRET (Förster 
resonance energy transfer) between two mutated XFPs, and Ca2+ mediated 
modulation of a single XFP. In the following section, designing concerns of GECIs 
will be discussed and representative examples will be given for each group.  
2.3.1 Ca2+ binding protein motifs 
In nature, there exists a variety of Ca2+ binding sites in proteins, but only two 
prominent types of intracellular Ca2+ binding motifs that can coordinate Ca2+ in the 
physiologically relevant range (Hilge, Aelen, Perrakis, & Vuister, 2007; Moldoveanu, 
Jia, & Davies, 2004). These motifs are C2 domains and EF-hands. C2 domains have 
been found in a huge number of different proteins, e.g., PLA2 (phospholipase A2), 
PLC (phospholipase C), PKC (protein kinase C), and synaptotagmin (Rizo & Südhof, 
1998). One characteristic of many C2 domains are that they bind Ca2+ and 
phospholipids, though some variants evolve to bind other targets. For example, 
phospholipid can act as a ligand for calcium binding in PKC-C2 domain, and it will 
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increase the affinity for Ca2+ binding. Another C2 domain, C2A domain of 
synaptotagmin I, the Kd of Ca
2+ binding can be decreased 1000-fold in the presence of 
phospholipids (Rizo & Südhof, 1998). Due to those interrelationship between 
phospholipids and Ca2+, C2 domains are not a first choice in most GECIs design. 
In contrast to C2 domains, EF-hands have Ca2+ as its only ligand. EF-hands have a 
helix-loop-helix motif of ~30 amino acids and usually form dimer, tetramer, hexamer 
or more protein complex. The most important part is the loop regions which give rise 
to the coordination space through predominantly negatively charged amino acid 
residues (Figure 2-2A).  
 
 
Figure 2-2 Structure of typical EF-hands and its Ca2+ binding center. (A) C-terminal 
EF-hand domain of chicken skeletal troponin C (csTnC, PDB file 1TOP, shown in 
yellow) complexed with two Ca2+ (shown in gray) (B) Blowup of the coordination in 
EF-hand III of csTnC (M. Mank & Griesbeck, 2008) 
 
Most EF-hand-containing proteins (e.g., troponin C & calmodulin) possess the so-
called canonical EF-hand. This version of the domain exhibits a 12-residue calcium-
binding loop consisting of nine residues in the loop region and three residues in the 
exiting helical part of the EF-hand (Figure 2-2B). For example, calmodulin forms two 
globular domains connected by a flexible central linker. Each domain binds two 
calcium ions in EF hand motifs, so that calmodulin can bind a total of four Ca2+ ions. 
The canonical EF-hand coordinates Ca2+ via a pentagonal bipyramid, i.e., through 
seven coordinating partners. The positions inside the 12-residue binding loop are 
referred as 1 (+X), 3 (+Y), 5 (+Z), 7 (-Y), 1 (-X), 12 (-Z). The numbers inside the 
position along the linear sequence of the loop, whereas letters indicate the position in 




Figure 2-3 Schematic of the Ca2+ coordination in a canonical EF-hand. Letters are 
positions of the residues that are involved in the Ca2+ coordination. Note that two 
ligands in the planar pentagon are provided by the same amino acid residue (-Z). (M. 
Mank & Griesbeck, 2008) 
 
According to functions of EF-hand containing proteins, EF-hand motifs can be 
categorized into two kinds: “regulatory” EF-hands that undergo a conformational 
change after calcium binding and “structural” EF-hands that do not (Grabarek, 2006). 
The regulatory hands are typical of proteins with important regulatory functions such 
as calmodulin (CaM), troponin C (TnC), and recoverin. These proteins typically 
mediate Ca2+ related physiology and biochemistry of a cell. Calmodulin forms two 
globular domains connected by a flexible central linker. Each domain binds two 
calcium ions in EF hand motifs, a motif ubiquitous in calcium-binding proteins, so 
that calmodulin can bind a total of four Ca2+ ions. The structural hands are found in 
buffer proteins such as calbindin D9K or parvalbumin which serve to shape the 
profile and duration of calcium signals within cells (M. Mank & Griesbeck, 2008). 
Since EF-hands motif commonly form pairs in proteins, they tend to stack against 
each other and improve mutual stabilization. As a consequence, calcium binding to 
EF-hands are often cooperative. In general, the first Ca2+ binding to EF hands will 
facilitate following Ca2+ binding due to favorable conformational change. Thus, most 
EF hands have positive cooperative Ca2+ binding kinetics. Last thing to note is that 
same as the chemically synthesized Ca2+ indicators, Kd of Ca
2+ binding motifs usually 
depend on pH and concentration of other ions (e.g. Mg2+, Cl-), hence it requires 
calibration each time before the real measurement (Palmer & Tsien, 2006). 
2.3.2 FRET-based GECIs 
Förster resonance energy transfer (FRET) is a spectroscopic phenomenon that the 
excited donor fluorophore transfers its excitation energy non-radioactively to a 
proximal ground-state acceptor fluorophore (Clapp, Medintz, & Mattoussi, 2006). 
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FRET is sensitive to changes in conformation, orientation and distance between donor 
and acceptor. The efficiency of FRET can be quantitatively described by the Förster 
equation (eq. 2-4), and it decreases sharply with increasing distance between donor 
and acceptor (Figure 2-4). In the equation, r is the actual distance between the  





                                              eq. 2-4 
fluorophores, and R0 is the distance at which energy transfer between a given donor-
acceptor pair is half-maximal (also called Förster distance). It should be noted that R0 
is a specific value for each individual donor-acceptor pair that depends on spectral 
overlap between donor emission and acceptor excitation, the donor quantum yield, 
and an orientation factor κ2. Typically, Förster distances are in the range of 20-80 Å. 
Using Ca2 binding motif to control the distance and orientation between donor and 
acceptor, FRET has been extensively exploited as GECIs. As mentioned in the section 
2.3.1, calmodulin (CaM) and troponin C (TnC) are two most commonly used Ca2+ 
binding motifs. Due to the interest of my work, most examples shown below will be 
based on CaM. The examples employing TnC can be found in Mank and Griesbeck’s 
review (2008).   
 
 
Figure 2-4 Dependency of FRET efficiency (EFRET) on the distance (r) between a 
donor-acceptor pair with an assumed Förster radius R0 of 50 Å. Note that the 
relationship is only linear with distance changes in the vicinity of R0.Therefore an 
idealized, approximately linear FRET reporter will preferably operate at EFRET values 





Figure 2-5 Calmodulin (CaM)/FRET-based GECIs (M. Mank & Griesbeck, 2008). 
See text for detail. 
 
One famous example is a group of GECIs called “Cameleons”. They utilize CaM and 
its binding peptide M13 from myosin light chain kinase as Ca2+ binding motif which 
sandwiched by enhanced blue fluorescent protein (EBFP) and enhanced green 
fluorescent protein (EGFP) (Figure 2-5). Upon Ca2+ binding to CaM, Ca2+/CaM is 
thought to wrap around the neighboring M13 peptide, thereby initiating a 
conformational change of CaM and bringing donor (EBFP) and acceptor (EGFP) to 
proximity, which increases FRET efficiency of the donor-acceptor pair in a manner of 
Ca2+ dependency. The reasoning for including the CaM-binding motif was first of all 
to increase conformational change of the protein complex. Second, the preferred 
intramolecular interaction of CaM with a flanking binding peptide was thought to 
prevent activating of CaM-dependent target proteins within a cellular environment. 
Early version of Cameleons uses BFP (or its mutant Enhanced BFP) as its donor, but 
it turned out that BFP were not suitable for live cell imaging, as they are dim and 
bleached rapidly. Therefore, the donor-acceptor pair was switched to cyan fluorescent 
protein (CFP) and yellow fluorescent protein (YFP) in yellow Cameleon 2.0 (YC2.0), 
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which obtains higher signal-to-noise ratio and more stable imaging in live cells at the 
cost of slightly higher spectral overlap of the CFP emission with the YFP emission 
band (A. Miyawaki et al., 1997). Tuning Ca2+ affinities can be achieved by site 
directed mutagenesis of chelating residues within EF-hand motifs of CaM (A. 
Miyawaki et al., 1997). Cameleon-2 with wild-type CaM was reported to have 
biphasic Ca2+ dependency with Kd’s of 70 nM and 11 μΜ, substitutes glutamate 104 
with glutamine located at the third Ca2+ binding loop of CaM resulted in Cameleon-3 
(YC 3.X) with a lower affinity Kd of 4.4 μΜ, while the mutation E31Q in Cameleon-4 
(YC 4.X) shifted affinities to Kd’s of 83 nM and 11 μΜ (A. Miyawaki et al., 1997). A 
problem of Cameleons is they have a small dynamic range, making subtle changes in 
[Ca2+] difficult to detect in some cells and organelles. Thus, in Cameleon-6 (YC6.X), 
CaM was split, and the CaM binding peptide derived from CaM-dependent kinase 
kinase (CKKp) was inserted to replace M13, which YC 6.1 displays a two-fold 
dynamic range increase at [Ca2+] from 0.05-1 μΜ (Truong et al., 2001). While CFP 
fluorescence remains relatively stable down to approximately pH 6, another line of 
improvement consisted in replacing YFP as acceptor. The first version of YFP has a 
pKa of 7.0, and it is too sensitive to small pH fluctuation in the cytosol which can 
range from 6.8 to 7.3 under various condition. Meanwhile, YFP is easily to be 
quenched by Cl- under physiological condition. Therefore, other variants of YFP were 
needed so that donor-acceptor fluorophores are insensitive to common physiological 
factors and only mediated by FRET. 
A first remedy was replacing YFP with YFP-V68L/Q69K in YC 2.1, which had a pKa 
of 6.1 (Atsushi Miyawaki, Griesbeck, Heim, & Tsien, 1999). Later the YFP variant, 
Citrine, with the mutation Q69M showed better results, which pKa was further shifted 
to 5.7 and also insensitive to chloride concentrations (Griesbeck, Baird, Campbell, 
Zacharias, & Tsien, 2001).  Subsequently another YFP variant called Venus in YC 
2.3/3.3/4.3 or YC 2.12 also exhibited less pH and Cl- sensitivity (Griesbeck et al., 
2001; Nagai et al., 2002). The most significant improvement was the development of 
circular permutation of GFP and its variants (cpXFPs). cpXFPs result from 
interchange of amino and carboxy portions of the wild-type XFP (Figure 2-6). The 
original N- and C- termini are linked via a short peptide sequence so that new N- and 
C- termini become available for fusing fluorophore to the Ca2+ binding motifs. 
Incorporating a circular permuted form of Venus (Venus cp173) as an acceptor into 
YC 2.60/3.60 resulted in a more than 5-fold dynamic range increase in emission ratio 
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Figure 2-6 Circular permutation of GFPs. (A) Circularly permutated (cp) variants are 
obtained by opening of the wild-type protein sequence at an additional site. The 
resulting fragments are interchanged and combined (permutated) by a short linker (in 
blue), which fuses the original N- and C- terminus. A number of permutations are 
possible in this way that can result in functional fluorophore. (B) Circular permutated 
proteins are thought to display the same 3D structures as their wild-type counterparts 
but have new N- and C- termini. (M. Mank & Griesbeck, 2008) 
 
2.3.3 Single fluorophore-based GECIs 
After a surprising discovery by Baird et al., that the β-barrel of GFP tolerated the 
insertion of large protein fragments without destroying fluorescence, it became 
feasible that using Ca2+ binding motifs to cause Ca2+-dependent single fluorophore 
conformation change. One widely used GECIs of this kind is GCaMP and its updates. 
In GCaMP, the N-terminus of cpEGFP was connected to M13 peptide, which is a 
target sequence of CaM, whereas the C-terminus of cpEGFP was connected to CaM 
(Figure 2-7). The cpEGFP in GCaMP was created by connecting the original EGFP 
terminus with amino acid sequence “GGTGGS” and deleting amino acid residues 
145-148 to make new N and C terminus (Figure 2-7A). When Ca2+ binds to CaM, 
conformational changes due to the Ca2+-CaM-M13 interaction induce a subsequent 
conformational change in cpEGFP, therefore fluorescence intensity increases. As it 
turned out, the linker sequences used to fuse M13 and CaM to the cpEGFP moiety are 
crucial for tuning response properties of GCaMP. Numerous rounds of structure-
guided optimization have been employed to improve sensitivity and provide various 
Ca2+ affinities (Chen et al., 2013; Hilge et al., 2007; Remington, 2006). So far, the 
latest version GCaMP6 provides great dynamic range, high Ca2+ affinity and three 





Figure 2-7 Schematic representation of GCaMP and its crystal structure. (A) GCaMP 
consists of the M13 (myosin light chain kinase), cpEGFP (circular permutated 
enhanced GFP) and CaM (calmodulin) located N to C terminally. (B) Schematic 
topology of GCaMP. (C) Crystal structure of GCaMP. (Chen et al., 2013) 
 









pKa, apo pKa, sat 
GCaMP3 13.5±0.7 345±17 2.54±0.04 2.57 8.44±0.01 7.13±0.07 
GCaMP5G 45.5±0.9 447±10 2.46±0.04 2.52 8.61±0.15 6.58±0.02 
GCaMP6s 63.2±3.1 144±4 2.90±0.17 1.12 9.77±0.70 6.20±0.02 
GCaMP6m 38.1±1.8 167±3 2.96±0.04 2.06 8.68±0.09 6.90±0.04 





2.4 Localized Surface Plasmon Resonance (LSPR) 
First, some physical concepts used below will be briefly explained. Plasmon is a 
physical concept (quasiparticle) to describe plasma oscillation, or in our case, the 
oscillation of surface conduction electrons on certain material surface. The materials 
that possess a negative real and small positive imaginary dielectric constant (usually 
metal) are capable of supporting a surface plasmon resonance (SPR). This resonance 
is a coherent oscillation mode which comprise an electromagnetic (EM) field coupled 
to the oscillations of surface conduction electrons. Surface plasmon refers to the 
oscillations of the surface conduction electrons excited by electromagnetic radiation, 
i.e., incident light. When the material is at a bulk scale (e.g. larger than micron), 
plasmons propagate in the x- and y- directions along the material-dielectric interface, 
for distances on the order of tens to hundreds of microns, and decay evanescently in 
the z-direction (perpendicular to the film) with 1/e decay lengths on the order of 200 
nm (Figure 2-8 A). When the size of the material shrinks into nanoscale, plasmon 
oscillates locally around the nanoparticle with a frequency known as the localized 
surface plasmon resonance (LSPR) (Figure 2-8 B). Both SPR and LSPR are sensitive 
to changes in the local dielectric environment and has been studied in several surface 
enhancement phenomena: surface-enhanced Raman scattering (SERS), hyper-Raman 
scattering, one- and two-photon absorption, second harmonic generation (SHG), and 
surface-enhanced luminescence/fluorescence. 
For many metals such as Pb, In, Hg, Sn, and Cd, SPR frequency lies in the UV part of 
the spectrum and nanoparticles do not display strong enhancement effects. Such small 
metal particles are also readily oxidized making LSPR application infeasible. The 
coinage elements are exceptional. First, they are more noble and form air-stable 
colloids. Second, due to d-d band transition, the plasma frequency is pushed into 
visible part of the spectrum, which makes bioluminescence enhancement possible. 
Theoretically, both SPR and LSPR can be well depicted by Mie’s theory (Mie, 1908). 
A full theoretical treatment of LSPR is beyond the scope of this review, which I 
would like to refer the interested reader to the Supplemental Appendix of Willets and 
Van Duyne’s review (2007). For my thesis purpose, we consider a spherical 
nanoparticle of radius a that is irradiated by z-polarized light of wavelength λ (where 
a is much smaller than the wavelength of light λ; i.e., a/ λ < 0.1). In this limit, we can 
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calculate the extinction spectrum1 of the metal sphere as follows (Willets & Van 
Duyne, 2007): 









]              (eq. 2-5) 
 Here, εr and εi are the real and imaginary components of the metal dielectric function, 
respectively, εout is the dielectric constant of the external environment, χ is the 
geometrical factor which is 2 for the case of a sphere, and N is the particle number 
which are excited by external light. From equation 2-5, we can learn that the 
frequency of LSPR depends not only on particle properties (shape, metal dielectric 
function, and particle number), but also on dielectric constant of the medium as well.  
Nanospheres, nanorods and silica-gold nanoshells are the most commonly used gold 
nanoparticles. By increasing the size of gold nanospheres from 20 to 80 nm, the 
magnitude of extinction as well as the relative contribution of scattering to the 
extinction rapidly increses (Jain, Lee, El-Sayed, & El-Sayed, 2006). For non-spherical 
nanoparticles, the extinction properties are determined by aspect ratio and the 
orientation of the external electric field relative to the particle as well (Liz-Marzan, 
2006). As the equation 2-5 showed, LSPR is also affected by the surrounding medium 
of nanoparticles, which can be reflected by its refractive index, n. Under dilute 
nanoparticle dispersion presumption, Mie theory predicts the resonance occurs when 
ε1(ω) = -2εm (ε1(ω) being the real component of the metal dielectric function at 
angular frequency ω, and εm the medium dielectric constant. However, when 
nanoparticle is concentrated, the situation will become more complicated since 
interactions between neighboring particles can arise (Miller & Lazarides, 2005). 
                                                 




Figure 2-8 Schematic diagrams illustrating (A) a surface plasmon polariton (or 
propagating plasmon) and (B) a localized surface plasmon. 
2.5 Gold Nanoparticle (AuNP) and Protein Conjugation 
When AuNPs are exposed to protein solution, proteins are easily absorbed onto the 
surface of AuNPs to form a protein corona around AuNPs, which reduces the surface 
free energy of AuNPs.  For example, AuNPs have been shown to absorb a variety of 
proteins such as ubiquitin (Tavanti, Pedone, & Menziani, 2015), serum albumin 
(Dominguez-Medina, McDonough, Swanglap, Landes, & Link, 2012), tumor necrosis 
factor (Tsai et al., 2012), cytochrome C (Aubin-Tam & Hamad-Schifferli, 2005), 
fibrinogen (Deng, Liang, Toth, Monteiro, & Minchin, 2012), etc. Different proteins 
have different binding site and binding affinities. Corona can be roughly divided into 
two types: hard and soft corona (P. Wang et al., 2015). Hard corona means that 
proteins are bound to the surface durably and tightly. In contrast, soft corona indicates 
that proteins are less tightly bound to the surface, which is dynamic and will exchange 
with proteins in the media with time (Milani, Baldelli Bombelli, Pitek, Dawson, & 
Rädler, 2012). When solution contains various proteins, the high abundance proteins 
first arrive at and bind on the surface of AuNPs to form soft corona, however, they 
will be eventually replaced by high-affinity proteins to form hard corona NP-proteins 
complexes (Rahman, Laurent, Tawil, Yahia, & Mahmoudi, 2013). Both chemical and 
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physical absorption take part in the formation of protein corona such as coordination, 
hydrogen bonding, Van der Waals forces, and hydrophobic interactions. For instance, 
when bovine serum albumin (BSA) interacts with AuNPs, the disulfide bonds of BSA 
absorb on the surface of AuNPs via at least 12 Au-S bonds (L. Wang et al., 2013). In 
contrast, ubiquitin is a small, cysteine free protein bound to citrate-coated AuNPs 
mainly via short-range, non-electrostatic interactions, such as hydrogen bonds, where 
the NH group binds to the central carboxylate group of surface citrate on AuNPs 
(Brancolini, Kokh, Calzolai, Wade, & Corni, 2012). There are three important factors 
that mediate the protein corona formation: AuNP size, hydrophobicity and surface 
chemistry. 
2.5.1 AuNP size 
The size of AuNPs determines the possible total amounts of absorbed proteins on the 
surface, since the size of AuNPs governs the curvature of AuNPs that have different 
protein binding constants. For example, polyacrylic acid (PAA)-coated AuNPs have 
negative charges on the surface and their sizes range from 7 nm to 22 nm. The 
binding affinities of the AuNPs to fibrinogen increases with the size of AuNPs (Deng 
et al., 2012). A similar study also showed that AuNPs ranging from 5 to 100 nm can 
interact with common human blood proteins including albumin, fibrinogen, globulin, 
histone, and insulin in a size-dependent manner, which indicates AuNPs with 
increasing sizes have stronger capability of binding to the proteins. They also 
suggested that the proteins undergo conformational change upon association with 
AuNPs, and that the thickness of the absorbed protein layer (size of AuNPs <50 nm) 
progressively increases with the AuNP sizes (Lacerda et al., 2009). Another team 
used gel electrophoresis and a combination of matrix-assisted laser 
desorption/ionization and time-of-flight mass spectrometry to quantitatively analyze 
and identify the mouse serum proteins absorbed on 5, 15 and 80 nm phosphine 
stabilized AuNPs with negative surface charges. They found smaller AuNPs have 
lower protein absorption than larger AuNPs because the former has a higher curvature 
that reduced the protein binding capacity (Schäffler et al., 2013). 
2.5.2 Hydrophobicity 
Hydrophobicity or hydrophilicity of AuNPs are crucial factors to mediate the 
composition and amount of protein absorption. A clean surface of gold is hydrophilic 
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(Bewig & Zisman, 1965). Hydrophobicity of AuNPs can be tuned by multiple surface 
modifications. For example, after modification with high density of hydrophilic 
polyethylene glycols (PEGs), AuNPs can resist the absorption of plasma proteins such 
as complement components (Fischer & Chan, 2007). In addition, AuNPs can be 
modified by both hydrophilic and hydrophobic thiolated ligand molecules, and by 
tuning their ratio, such surface heterogeneity can serve as a tunable property to 
modulate the conformation of absorbed proteins (Huang, Carney, Ikuma, Stellacci, & 
Lau, 2014). Moreover, for the same AuNPs, when compared with their hydrophilic 
counterparts, hydrophilic AuNPs can absorb more proteins from blood plasma 
(Lindman et al., 2007). 
2.5.3 Surface chemistry 
Pure AuNPs are not stable enough due to high surface free energy, thus, the surface of 
AuNPs is usually capped with citrate, cetrimonium bromide (CTAB), polyethylene 
glycol (PEG), silica or silica-PEG to increase their dispersibility and functionality. 
Surface chemistry not only affects the quality of AuNPs (stability, monodispersity, 
and biocompatibility) but also provides functional groups (-COO-, -NH3
+, -CHO, etc.) 
or charges that can be exploited for bioconjugation or ligand exchange. For example, 
the amount of protein absorbed on the PEGylated AuNPs depend on both the size of 
the AuNPs and the density of grafted PEG. Specially, the greater the PEG coating 
density, the smaller the amount of absorbed proteins on the surface (Walkey, Olsen, 
Guo, Emili, & Chan, 2012). Since Au can form many charge-neutral complexes, these 
Au chemistries have been extensively used in the surface modification of AuNPs to 
specifically conjugate with other biomolecules. For example, a wide range of 
molecules can be tethered onto the AuNPs surface by means of thiol (-SH) group. 
Cysteine can easily conjugate to the AuNPs through Au-S bond. After mutated to 
present an exposed cysteine residue, a single chain Fv antibody fragment (scFv) can 
form a gold-thiolate bond efficiently with AuNPs by chemical oxidation (Ackerson, 
Jadzinsky, Jensen, & Kornberg, 2006). Triphenylphosphine can also form 
coordination complex with Au. Triphenylphosphine can be synthesized with 
nitrilotriacetic acid (NTA) before coordinate with AuNPs, and the subsequent NTA-
AuNPs can bind with histidine through nickel chelating system (Hainfeld, Liu, Halsey, 




CHAPTER 3 ULTRASENSITIVE BIOLUMINESCENT CALCIUM 
INDICATOR PROTEIN 
3.1 Introduction 
Although newly developed FRET based GECIs exhibited high sensitivity and 
excellent dynamic range, implantation of fiber optics or craniotomy (exposure of the 
brain through a glass coverslip or the thinned skull) is essential for their excitation in 
vivo (Chen, 2013). However, such implantation (normally inserted into brain tissue 
and affixed to the animal skull) still has several limitations, which could impair the 
results accuracy. For example, light emission can be visibly noticeable at the interface 
between the patch cable and the implanted optical fiber at high light-output intensities. 
If this is left unattended, it may serve as an unwarranted cue to the animal during 
behavioral sessions and may alter responses (Martin-Garcia et al., 2011). Other 
possible limitations include tissue damage during implantation, fibers breaking upon 
removal from brain tissue, and difficulties with long-term control (Sparta et al., 2011).  
Combining the distinct advantages of FRET and bioluminescence approaches would 
create unprecedented opportunities for monitoring intracellular Ca2+ level at a wide 
range of spatial and temporal scales. To allow noninvasive monitoring of [Ca2+] using 
light signal, we proposed two bioluminescence resonance energy transfer (BRET) 
based calcium indicators, GCaMPGLuc and GLucGCaMP; and one negative control, 
GCaMP2AGLuc, to prove the BRET mechanism of the indicators (Figure 3-1). 
Gaussia luciferase (GLuc; 185 aa, 19.9 kDa) is the smallest secreted luciferase known 
and is naturally secreted (Bornhop et al., 1999). The two BRET calcium indicators are 
fusion proteins composed of a “slow-burn” Gaussia luciferase (sbGLuc; M43L and 
M110L) (Welsh, Patel, Manthiram, & Swartz, 2009) without its native secretion 
signal and fluorescence based Ca2+ indicator GCaMP6s (Chen et al., 2013). When 
Ca2+ binding on M13 in GCaMP6s triggers conformational change in cpEGFP, the 
light generated by the luciferase as donor with coelenterazine (CTZ) will be 
transferred to excite cpEGFP as acceptor. This energy transfer between donor and 
acceptor is called BRET and obeys similar physical rules as FRET. The ratio of light 
emission of sbGLuc (donor) versus GCaMP6s (acceptor) will indicate the Ca2+ level. 
GCaMP2AGLuc, on the other hand possesses a T2A (Thosea asigna virus 2A) “self-
cleaving” peptide sequence inserted between GCaMP6s and sbGLuc, where ribosome 
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skipping on the T2A sequence will release two separate translational products (Figure 
3-2). Since BRET requires close proximity between donor and acceptor proteins for 
efficient energy transfer (see section 2.3.2), T2A sequence in GCaMP2AGLuc should 
interrupt this process and lose dependency with changing [Ca2+], which provides an 
important negative control of BRET mechanism of the two proposed indicators.  
In this study, I will determine the Kd of GCaMPGLuc, GLucGCaMP and 
GCaMP2AGLuc under either BRET or fluorescence intracellular working condition 
in vitro. To accurately calibrate intracellular free [Ca2+], a series of standard EGTA-
CaEGTA Ca2+ buffer mixed with ionomycin and nigericin will be used to equilibrate 
intracellular [Ca2+] with extracellular standard Ca2+ buffer solution (Petr & Wurster, 
1997). Specifically, the equilibrium of EGTA mixing with CaEGTA (Kd
EGTA=150.5 
nM at 20°C, pH 7.20, 0.1M KCl) in different ratios can generate a series of Ca2+ 
buffer with a similar range to typical intracellular [Ca2+] dynamics. Adding 
ionomycin and nigericin to this standard EGTA-CaEGTA buffer can then equilibrate 
intracellular [Ca2+] with the known extracellular standard Ca2+ solution. Ionomycin is 
a Ca2+ ionophore that is used to equilibrate the intracellular concentration with the 
known extracellular standard solution. Nigericin is a hydrogen ionophore used to 
maintain an intracellular proton concentration equal to the extracellular buffer 
solution. Thus, a stable intracellular environment is maintained in terms of ionic 
strength, temperature and pH. 
There are several advantages of BRET-based GECIs compared with other GECIs. 
Using the ratio of two individual emission spectrum also improves the robustness as 
Ca2+ indicator compared with the single fluorescence emission spectrum of GCaMP6s, 
because the latter will be influenced by a variety of environmental factors (O’Connor, 
2007), and requires more stringent in situ calibration, which will be tedious and 
challenging for some in vivo application (Chen, 2013). Also, the sbGLuc substrate, 
CTZ are highly hydrophobic molecules, hence easily to penetrate tissue barrier (e.g. 
blood brain barrier) to reach the targeted cells (Berglund, 2016). Since there is no 
obvious structure interference on GCaMP6s, the two BRET Ca2+ indicators should 
work both as a ratiometric bioluminescent sensor as well as intentiometric 
fluorescence sensor. 
Capitalizing on GCaMPGLuc and GLucGCaMP working as both BRET and single 
fluorescence based Ca2+ indicators, our approach offered a novel noninvasive GECIs, 
which integrates ratiometric and single wavelength Ca2+ measurements by preserving 
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externally excitable GCaMP6s where desired, while at the same time providing the 
bioluminescence of sbGLuc to excite GCaMP6s intramolecularly, thus allowing 
flexible monitoring of intracellular Ca2+ over a range of spatial and temporal scales 
both in vivo and in vitro.  
 
 
Figure 3-1 Schematic representation of sbGLuc and GCaMP6s based Ca2+ indicators 
and corresponding 2A negative control. Both GCaMPGLuc and GLucGCaMP are 
fusion proteins of GCaMP6s and sbGLuc/ΔSS, which interchanges their fusion order. 
GCaMP6s consists of the M13 fragment from myosin light chain kinase (M13), a 
circularly permutated EGFP (cpEGFP) and calmodulin (CaM) located N to C 
terminally. When binding with Ca2+, conformational change triggered by M13 and 
CaM proximity will form closed and functional EGFP that can be excited by sbGLuc 
through bioluminescence resonance energy transfer (BRET). Self-cleaving 2A 
sequence in GCaMP2AGLuc will disconnect GCamP6s and sbGLuc/ΔSS, and BRET 





Figure 3-2 Schematic representation of the mechanism of “self-cleaving” 2A peptides. 
When the ribosome encounters a 2A sequence, a “ribosomal -skip” or “STOP&GO” 
occurs and a first polypeptide is released while translation of the messenger RNA 
(mRNA) continues. (Liu et al., 2017). 
3.2 Methodology 
3.2.1 Plasmid Design 
All the restriction enzymes used below are bought from New England Biolabs, USA, 
unless specified. First, “slow-burn” variant of Gaussia luciferase (sbGLuc, mutated at 
M43L and M110L) was partially subcloned into pcDNA3.1(+) mammalian 
expression vector, where the secretion signal of the sbGLuc was removed during 
subcloning. The subsequent vector was named as pcDNA3.1-CAG-sbGLuc/ΔSS, and 
its expressed protein refers as sbGLuc. This plasmid was already made before this 
study. 
pGP-CMV-GCaMP6s was obtained from Addgene (Plasmid #40753), and its 
expressed protein refers as GCaMP6s. GCaMP6s from the pGP vector was PCR 
amplified with the forward primer “TATGGCTAGCATGACTGGT” and the reverse 
primer “CGCGGCCGCAAGCTTCGCTGTCAT” and cut with BmtI-HF and HindIII-
HF to create BmtI site with 3’ overhang and HindIII site with 5’ overhang. 
pcDNA3.1-CAG-sbGLuc/ΔSS was then cut by BmtI-HF and HindIII-HF, and 
annealed with the GCaMP6s PCR amplified insert, where GCaMP6s located at the N 
terminal of sbGLuc/ΔSS with one leucine as a linker. The subsequent vector was 
named as pcDNA3.1-CAG-GCaMP6s-sbGLuc/ΔSS, and its expressed protein refers 
as GCaMPGLuc.  
pcDNA3.1-CAG-sbGLuc/ΔSS was also cut by NotI-HF, so did the PCR amplified 
GCaMP6s insert with the forward primer “GGCCGCGGTCGACTCATC” and the 
reverse primer “CGCGGCCGCAAGCTTCGCTGTCAT”. Then, the GCaMP6s insert 
was anneal with the nick of NotI site on pcDNA3.1-CAG-sbGLuc/ΔSS, where 
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GCaMP6s located at the C terminal of sbGLuc/ΔSS with 3 alanine as a linker. The 
subsequent vector was named as pcDNA3.1-CAG-sbGLuc/ΔSS-GCaMP6s, and its 
expressed protein refers as GLucGCaMP.   
Finally, T2A “self-cleaving” peptide sequence was inserting between GCaMP6s and 
sbGLuc/ΔSS in pcDNA3.1-CAG-GCaMP6s-sbGLuc/ΔSS by QuikChange II Site-
Directed Mutagenesis Kit (Agilent, USA). Specifically, the forward primer 
“AGCTCGAGGGCCGCGGCTCCCTGCTGACCTGCGGCGACG-
TGGAGGAGAACCCCGGGCCCA” and its complementary reverse primer were 
used to amplify unmethylated PCR products containing the T2A insert, and the 
methylated parental template plasmids were destroyed by DpnI following the 
manufacturer’s instructions. The subsequent vector was named as pcDNA3.1-CAG-
GCaMP6s-2A-sbGLuc/ΔSS, and its expressed protein refers as GCaMP2AGLuc. The 
completed amino acid sequences of each plasmid product are shown in Figure 3-3. 
 
 
Figure 3-3 Simplified amino acid sequences of GCaMPGLuc, GLucGCaMP and 
GCaMP2AGLuc. Specifically, 2A in GCaMP2AGLuc is T2A peptide.  
 
3.2.2 Bioluminescent Intracellular Ca2+ Response in HEK293 Cells 
HEK293 cells were maintained in Dulbecco’s Modified Eagle Medium, high glucose 
with phenol red (DMEM, Sigma) and supplemented with 10% (V/V) fetal bovine 
serum (Atlanta Biologicals, USA) and 1% (V/V) penicillin-streptomycin (P/S, Sigma) 
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under 37 °C and 5% CO2. Cells were plated in a 96-well white plate with clear flat 
bottom (ref# 655098, Greiner Bio-One), and the cell culture medium was changed 
with high Glucose DMEM (10% FBS, 1% P/S) without phenol red (Sigma). When 
desired cell confluency was reached, except for H row, every three columns were 
transfected with GCaMPGLuc, GLucGCaMP, GCaMP2AGLuc, and sbGLuc using 
Lipofectamine 2000 (Invitrogen) following the manufacturer’s instructions in a 
manner of Figure 3-4. After incubating 24 hr, the medium was aspirated carefully and 
replace with the volume of EGTA and 39 μΜ Ca-EGTA buffer (pH 7.20, 
Kd
EGTA=150.5 nM under 20°C in 0.1 M KCl, Biotium, USA) as represented in figure 
3-4. Both EGTA and 39 μΜ Ca-EGTA buffer was diluted with 20 μΜ coelenterazine 
(NanoLight, USA), 10 μΜ ionomycin, and 4 mg/L nigericin (Petr & Wurster, 1997)  
(Sigma, USA) before use. After equilibrium for at least 5 min, the intracellular free 
[Ca2+] should be 39, 1.35, 0.351, 0.226, 0.150, 0.0376, 0.0167, 0.150 μΜ from row A 
to row H. The white plate was then read for relative luminescence intensity (RLU) in 
the plate reader (FLUO star OPTIMA, BMG Labtech, Germany) through three 
channels. One channel is through 485/12 nm (center wavelength/full width at half 
maximum) filter to measure RLU of sbGLuc emission, the other is through 520/10 
nm filter to measure RLU of cpEGFP emission, and the last one is through a lens 
without any filter to measure RLU of total emission.  
 
 
Figure 3-4 Plate arrangement of transfection and free Ca2+ calibration. The top of the 
plate shows the arrangement of plasmid transfection. Each plasmid transfected with 
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three adjacent columns, except for the H row without any transfection as a control 
group. The left of the plate shows the volume of EGTA and 39 μΜ CaEGTA buffer 
that was added into each well in the same row.  
3.2.3 Fluorescent Intracellular Ca2+ Response in HEK293 Cells 
HEK293 cells was maintained the same as mentioned in section 3-2. The cells were 
then plated in a 96-well black plate with clear flat bottom (ref# 4680, Corning), and 
the cell culture medium was changed with high glucose DMEM (10% FBS, 1% P/S) 
without phenol red. When desired cell confluency was reached, except for the H row, 
every three adjacent columns were transfected with GCaMPGLuc, GLucGCaMP, 
GCaMP2AGLuc, and GCaMP6s. The well arrangement was similar to the white plate 
in Figure 3-4 except for switching sbGLuc to GCaMP6s. After incubating 24 hrs, the 
medium was aspirated carefully and replaced with the volume of EGTA and 39 μΜ 
Ca-EGTA buffer (pH 7.20, Biotium, USA) as represented in Figure 3-4. Both EGTA 
and 39 μΜ Ca-EGTA buffer was diluted with 10 μΜ ionomycin, and 4 mg/L 
nigericin (Petr & Wurster, 1997) before use. After equilibrium for at least 5 min, the 
intracellular free [Ca2+] should be 39.0, 1.35, 0.351, 0.226, 0.150, 0.0376, 0.0167, 
0.150 μΜ from row A to row H. Then, fluorescent imaging of each well was 
performed using a Leica DM IRE2 inverted microscope (Leica, Germany) equipped 
with a Leica CTR MIC controller and a RetigaEX camera (QImaging, Canada). The 
objective was a ×10 lens (Leica HC PL Fluostar P/N 513852). Images were collected 
at 20 MHz (1360 x 1036 pixels, 16 bit), 1 second exposure time, 4 signal gains, and 0 
offset (SimplePCI imaging software). Excitation filter is a 470/40 nm bandpass filter 




Figure 3-5 Workflow of the image analysis. 
 
Raw images transfected by the same plasmid (e.g. images of cells expressing 
GCaMPGLuc in the black plate) were imported into ImageJ as stacks (for details see 
https://imagej.nih.gov/ij/docs/ index.html) to group analysis average RFU based on 
total cells in the field (Figure 3-5). First, I chose an appropriate threshold setting so 
that most cells in each image has been properly selected as region of interest (ROI) 
and background has been avoided. Second, average RFU of ROI in each image in 
stacks was measured, and it’s worth to note that calculated RFU here is actually 
grayscale of ROI in 16 bit which ranges from 0 to 65535, so it is important to avoid 
choosing saturated pixels as ROI in the first step since they are overexposed. Third, 
by using particle analysis (Size (pixel^2): 40-2000; Circularity: 0.00-1.00; Show: 
ellipses; check the boxes of Clear results, Include holes, and Summarize), total cell 
numbers and their standard deviation (SD) in ROI of each image was calculated. 
Fourth, reset the ROI, randomly chose 3 or 4 small circles from background (no cells) 
as new ROI in each image, and measured average RFU of the ROI in each image as 
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background signal. Finally, the background signal was subtracted from the average 
RFU obtained in the second step, and standard error of the mean (SEM) was 
calculated using the total cell numbers and their standard deviation from the third step. 
Since there are three replicates with the same transfected plasmid and free 
intracellular [Ca2+] in the black plate (see Figure 3-4), chose the calculated result of 
one image within three replicates to plot Figure 3-8 so that its value fits sigmoidal 
curve best. 
3.3 Results and Discussion 
3.3.1 Structure-based Design of the Ca2+ Indicators 
We designed two genetically encoded Ca2+ indicators (GECIs), GCaMPGLuc and 
GLucGCaMP. Both of them contain a single fluorophore-based GECI GCaMP6s 
(Chen, 2013), and a “slow-burn” mutated Gaussia luciferease (sbGLuc) (Welsh et al., 
2009). As showed in Figure 3-1, GCaMPGLuc is a fusion protein of GCaMP6s and 
sbGLuc/ΔSS located N to C terminally, whereas GLucGCaMP switches the position 
such that GCaMP6s located after C terminal of sbGLuc/ΔSS.  
Because bioluminescent resonance energy transfer (BRET) obeys similar rules as 
Förster resonance energy transfer (FRET), the distance between donor and acceptor 
should within Förster distances for efficient energy transfer, which is typically 20-80 
Å (see section 2.3.2). Based on the very similar crystal structure of GCaMP6m 
(another variant of GCaMP6 with K78H, M378G, K379S mutation compared to 
GCaMP6s), the distances from N and C terminus of GCaMP6s fused to sbGLuc to the 
fluorophore of cpEGFP are around 30 and 50 Å, respectively. Hence, the structure-
based designs of GCaMPGLuc and GLucGCaMP satisfied the proximity requirement 
between donors and acceptors which is required for the efficient BRET.  
When free Ca2+ binds to CaM of GCaMP6s part, conformational changes due to the 
Ca2+-CaM-M13 interaction induce a subsequent conformational change in cpEGFP, 
so that the fluorescence intensity excited by sbGLuc changes. Specifically, at low 
Ca2+ level, the barrel structure of cpEGFP is disrupted by M13 and CaM that fused at 
its two termini. Ca2+ binding on CaM will recruit its binding patterner M13, hence 
form closed and functional EGFP, which is then excited by sbGLuc emission. Thus, 
the ratio of cpEGFP emission and sbGluc emission can be used as an indicator of 
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[Ca2+]. Meanwhile, our fusion design does not disturb the original function of 
GCaMP6s part, and it can still be used as a fluorescence Ca2+ indicator alone. 
 
 
Figure 3-6 Crystal structure of GCaMP6m from the top view (Ding, Luo, Hu, Wang, 
& Shao, 2014). The rainbow color of the structural diagram indicates the N terminal 
(in red) to C terminal (in blue). The four bounded Ca2+ is colored in green sphere. The 
distances (yellow dash line) were measured from the α-carbon of the terminal amino 
acid to the oxygen of aliphatic hydroxyl group on the cpEGFP fluorophore (processed 
in PyMOL). 
 
3.3.2 Intracellular Ca2+ Response in HEK293 Cells 
We tested our indicators in HEK293 cells for intracellular Ca2+ response. When 
supplied with CTZ, our BRET-based indicators exhibited excellent Ca2+ dependency. 
Figure 3-7A shows the emission ratio of the GCaMP6s moiety (EM 520 nm) versus 
the sbGLuc moiety (EM 485 nm), which depends on BRET between GCaMP6s and 
sbGLuc, when supplied with EGTA-CaEGTA gradient buffer and CTZ. The degree 
of BRET efficiency is regulated by conformational change induced by Ca2+ binding in 
the GCaMP6s moiety and by the distance and orientation between sbGLuc (donor) 
and GCaMP6s (acceptor). CaM will recruit M13 after binding with Ca2+, and this will 
lead to close and functional conformation of cpEGFP, which can be excited by 
sbGLuc emission light. When “self-cleaving” peptide sequence 2A was inserted 
between GCaMP6s and sbGLuc in GCaMP2AGLuc, BRET between sbGLuc and 
cpEGFP was interrupted, and it is acting the same as sbGLuc alone, which is not Ca2+ 
dependent. The emission ratio of GCaMPGLuc and GLucGCaMP were normalized 
and least square-fitted with the Hill equation as shown in Figure 3-7B. Given such 
calibration data, the [Ca2+] in an unknown intracellular environment expressed with 
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the GECIs can be deduced from the sigmoidal curve of the ratio-[Ca2+] response. An 
explicit formula for this calibration is derived under 2.1.1Ca2+ Affinities. 
 
 
Figure 3-7 In vitro Ca2+ titration by BRET. A) Emission ratio of 520 nm over 485 nm 
at different [Ca2+]. B) Normalized emission ratio by (R - Rmin)/(Rmax - Rmin), where R 
is the ratio in A), then fitted with the Hill equation. Error bars represent SEM, and n = 
3. 
 
Figure 3-8 illustrates BRET process during Ca2+ binding. When [Ca2+] is increased, 
the induced conformational changes in cpEGFP of the GCaMP6s moiety of 
GCaMPGLuc and GLucGCaMP enable more emission light from sbGLuc to be 
transferred to excite the cpEGFP moiety, whereas neither GCaMP2AGLuc nor 
sbGLuc can exhibit such energy transfer. As seen in Figure 3-8, with increasing 
[Ca2+], the ratio of donor sbGLuc emission of 485 nm in GCaMPGLuc and 
GLucGCaMP is decreasing, while the ratio of acceptor cpEGFP emission of 520 nm 
in GCaMPGLuc and GLucGCaMP is increasing. The range of [Ca2+] where this 
intramolecular energy transfer happened are also the same as Figure 3-7. The 
emission ratio of GCaMP2AGLuc and sbGLuc was relatively stable and unrelated 
with the changes of [Ca2+]. 2A amino acid sequence of GCaMP2AGLuc caused 
ribosome skipping during translation, and sbGLuc and GCaMP6s was separate, 
preventing BRET from occurring. Hence, GCaMPGLuc and GLucGCaMP are indeed 





Figure 3-8 Donor-acceptor energy transfer. A) Emission ratio of 485 nm over total 
light through a clear lens. B) Emission ratio of 520 nm over total light through a clear 
lens. 
 
Figure 3-9A reveals that when excited solely by the external light, the GCaMP6s part 
of GCaMPGLuc, GLucGCaMP, and GCaMP2AGLuc acted similar as GCaMP6s 
alone as Ca2+ indicators. The fluorescence was weak at low [Ca2+], and gradually 
increased until saturation due to conformational change in M13-cpEGFP-CaM 
triggered by Ca2+ binding. Figure 3-9B showed the normalized fluorescence intensity, 
which was then fitted with the Hill equation. However, we need to point out that the 
overall signal intensity of RFU is not as strong as bioluminescence signal, and the 
background signal from auto-fluorescence is much worse especially in GCaMPGLuc 
and GCaMP2AGLuc. This, on the other hand, proved the advantage that ratiometric 
based BRET GECIs do not impair by the same systematic errors that affecting both 
wavelengths such as CTZ concentration, cell numbers, transfection efficiency, 
expression level, optical path length and absolute sensitivity of the instrument, 
because they will be cancelled out in the ratio results. Still, we showed that the 
GCaMP6s moiety in GCaMPGLuc and GLucGCaMP can function by itself as a 




Figure 3-9 In vitro Ca2+ titration by fluorescence. A) Fluorescence intensity response 
excited by the external light source. Legend is the same as B). B) Normalized 
fluorescence intensity response by (F – Fmin)/(Fmax – Fmin), where F is the RFU, then 
fitted with the Hill equation (continuous lines). Error bars represent SEM. 
 
In Table 3, we summarized dynamic range, apparent Kd, effective Kd, and Hill 
coefficient of the Ca2+ indicators we used in this study and compared them with 
previously published Ca2+ titration experiments using the purified GCaMP6s. The 
effective Kd is only applicable to the ratiometic GECIs (i.e., BRET based 
GCaMPGLuc and GLucGCaMP) and corrected by 485 nm emission intensity (λ2 = 
485 nm in the relation (5) from 2.1.1Ca2+ Affinities ) to make them comparable with 
the apparent Kd of single wavelength based GCaMP6s. The detailed discussion about 
the difference between apparent Kd and effective Kd is under 2.1.1Ca
2+ Affinities. 
Back to Table 3, the apparent Kd of BRET based GLucGCaMP is 84% bigger than the 
apparent Kd
 of BRET based GCaMPGLuc, whereas such difference is reduced to 26% 
in comparing the effective Kd where the systematic bias from 485 nm on Kd was 
eliminated. After considering the systematic error of the instrumental measurement, 
GCaMPGLuc and GLucGCaMP have similar Ca2+ affinities. The effective Kd of 
BRET based GCaMPGLuc is 55% larger than the reported apparent Kd of GCaMP6s, 
and the effective Kd of BRET based GLucGCaMP is 15% larger than the reported 
apparent Kd of GCaMP6s. After considering the systematic error of the instrumental 
measurement, BRET based GCaMPGLuc and GLucGCaMP have similar Ca2+ 
affinities with GCaMP6s, which means fusing sbGLuc on the N or C terminus of 
GCaMP6s doesn’t have remarkable influence on its Ca2+ affinities. 
When used as fluorescence-based GECIs, the GCaMP6s parts of GCaMPGLuc and 
GLucGCaMP showed larger difference in apparent Kd than worked by BRET, where 
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GCaMPGLuc showed much less affinity on Ca2+ than GLucGCaMP. This difference 
might be expanded by our less accurate measurement of RFU, because of the 
insufficient block of auto-fluorescence background and the risk of excitation light 
passing through due to close excitation-emission bandwidth. Thus, such difference 
cannot be the firm evidence that sbGLuc fused to GCaMP6s affects the Ca2+ binding 
property of GCaMP6s. Not surprisingly, the GCaMP6s part of GCaMP2AGLuc 
displayed similar affinity on Ca2+ binding, since the ribosome skipping caused by the 
inserted T2A sequence generated separate sbGLuc and GCaMP6s. 
Intriguingly, it is noticeable that GCaMP6s exhibited different Ca2+ binding affinities 
under purified form than expressed in HEK293 cells, where GCaMP6s in the cell has 
lower Kd, less Hill coefficient. This means GCaMP6s in the cell binds more tightly 
with Ca2+, and this binding process is less cooperative than the purified proteins. Such 
differences are caused by a variety of factors in the living cell, and one important 
reason could be the competitive binding of M13 with endogenous CaM (M. Mank & 
Griesbeck, 2008). Also, the dynamic range of GCaMP6s in living cell is heavily 
reduced compared with the measurement of the purified one. This is most likely 
caused by heavy auto-fluorescence background from the living cell.  
 
Table 3 Biophysical properties of Ca2+ indicators in HEK293 Cells 







Hill coefficient Mechanism Reference 
GCaMPGLuc 1.68 205.9/223.3 1.34 BRET This study 
GLucGCaMP 1.93 33.9/165.5 2.30 BRET This study 
GCaMP6s part of 
GCaMPGLuc 
1.59 658.2 2.29 Fluorescence This study 
GCaMP6s part of 
GLucGCaMP 
2.59 12.4 3.08 Fluorescence This study 
GCaMP6s part of 
GCaMP2AGLuc 
2.47 177.5 0.99 Fluorescence This study 
GCaMP6s 1.69 47.9 2.25 Fluorescence This study 
GCaMP6s 
(Purified Protein) 
63.2  144 2.90 Fluorescence Chen, 2013 




*  (Continue) Effective Kd is only applicable to the BRET based GECIs, which the 
calculation are modified to eliminate the systematic bias of apparent Kd from 485 nm 
emission, see 3.3.3Evaluation of Performance for detail. 
 
3.3.3 Evaluation of Performance 
In the work described here, I developed two [Ca2+] indicators based on BRET 
between sbGLuc and GCaMP6s. They both exhibited similar affinities and positive 
cooperative binding with Ca2+. There are two major advantages of our designed 
indicators compared with the original GCaMP6 series. First, both are BRET-based 
ratiometric indicators. The original GCaMP6 series are based on total fluorescence 
change with Ca2+ binding condition, and the fluorescence emission may be influenced 
by a variety of factors, such as transfection efficiency, cell numbers, intensity of 
excitation light, optical length, etc. The uncertainties associated with quantitating 
single-wavelength fluorescence emission require that GCaMP6 need to be calibrated 
with Ca2+ gradient buffer in situ each time before use (Palmer & Tsien, 2006), which 
may be burdensome for many in vivo studies. Another difficulty of using GCaMP6 is 
high auto-fluorescence background from living cells, and I faced the same issue when 
trying to read fluorescence intensity directly from the plate reader (over 90% signal 
was auto-fluorescence background). These limitations can be overcome through 
indicating [Ca2+] by the ratio of two independent emission wavelength as in our 
design, which cancel out the difference of cell numbers, expression level, transfection 
efficiency, optical path length and absolute sensitivity of the instrument. Hence, the 
ratiometric based GCaMPGLuc and GLucGCaMP are more robust than single 
fluorophore based GCaMP6. This has also been proved by our replicate experiment 
using the same experiment setting performed at several months interval (Figure 3-10). 
Second, both of GCaMPGLuc and GLucGCaMP can work by either BRET 
noninvasively with the luciferase substrate CTZ or via fluorescence by exciting the 
GCaMP6s moiety alone. Some tissue like brain is extremely fragile to optical fiber 
installation and possible phototoxicity that could impair the measurement accuracy of 
fluorescence based Ca2+ indicators. Hence, our BRET based indicators working on 
nontoxic CTZ provide wide flexibility on both in vivo and in vitro studies. However, 
compared with the purified GCaMP6s, the dynamic range of GCaMPGLuc and 
GLucGCaMP is greatly diminished. It is not clear if this is caused by absorption of 
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bioluminescence and auto-fluorescence from living cell components, which could 
reduce the maximal ratio at saturated [Ca2+]. It is also possible that close bandwidth of 
our filter setting (Emission filter 485/12 for 485 nm donor channel and 520/10 for 520 
nm acceptor channel) allows too much excitation light from the donor pass through 
the 520/10 nm filter to be received as acceptor fluorescence signal, thus the change in 
the nominator of the ratio (EM 520 nm) is heavily reduced.  
 
 
Figure 3-10 Emission ratio of GCaMPGLuc and GLucGCaMP on two dates separated 
six months exhibits consistent response. Error bars represent SEM, n = 4 for day1, 




CHAPTER 4 GOLD NANOPARTICLE ENHANCED 
BIOLUMINESCENCE 
4.1 Introduction 
4.1.1 Introduction of luminopsin 
Since Au nanoparticles (AuNPs) have great potential to enhance bioluminescence of 
luciferase by LSPR, this enhancement arises great interest in many luciferase 
applications including optogenetics. In the broadest sense, optogenetics encompasses 
a core technology – targetable control tools that respond to light and deliver effector 
function – and enabling technologies for (i) delivering light into tissues under 
investigation, (ii) targeting the control tools to cells of interest and (iii) obtaining 
compatible readouts and performing analysis, such as targeted imaging or electrical 
recording of evoked activity (Deisseroth, 2011). Luminopsins are one group of 
optogenetic probes that are fusion proteins of luciferase and opsins, which leverage 
bioluminescence of luciferase with its substrate to activate opsin to control certain cell 
activities. Berglund et al. (2016) in our lab reported LMO3, a luminopsin based on 
Volvox channelrhodopsin1 (VChR1) and “slow burn” mutant of Gaussia luciferase 
(sbGLuc). LMO3 is a fusion protein that sbGLuc, VChR1 and EYFP were fused N to 
C terminally (Figure 5-2, GLucG(LMO) without Kir2.1 trafficking signal). sbGLuc is 
a “slow-burn” mutant of native GLuc, which has been shown with increased light 
intensity and delayed emission half-life (Welsh et al., 2009). VChR1 is an algal light-
gated cation channel, which is composed of a seven-transmembrane helix domain 
with the all-trans-retinal chromophore and a C-terminal tail of unknown function 
(Ernst et al., 2008). EYFP at the C terminus of VChR1 allows identification of 
transfected cells. When expressed in cells, the native secretion signal at the N 
terminus of sbGLuc will be located outside of the cell membrane and tethered to the 
membrane domain VChR1, whereas EYFP at C terminus of VChR1 will stay inside 
the cell membrane (Figure 4-2). LMO3 has showed to generate subthreshold 
depolarizations upon application of coelenterazine (CTZ), the substrate of GLuc, and 
activate neurons in vitro and in vivo (Berglund et al., 2016). However, the emission of 
sbGLuc is still not bright enough to fully activate VChR1 compared with a physical 
light source at saturating intensity. To address this problem, on the one hand, a Kir2.1 
43 
 
trafficking signal was inserted between VChR1 and EYFP to improve the surface 
expression in neurons, and the subsequent probes was names as enhanced LMO3 
(eLMO3)(Zhang, Tung, Gross, & Berglund, (In preparation)); on the other hand, it is 
desirable to enhance the emission light of sbGLuc. Hence, to solve this problem, I 
proposed a simple strategy that hexahistidine tag (his-tag) was inserted in eLMO3 and 
conjugated with Ni-NTA-Au nanoparticle to enhance bioluminescence of sbGLuc. 
4.1.2 Ni-NTA-Au conjugation with histidine 
 
 
Figure 4-1 Schematic representation of Ni-NTA-Au binding with histidine and its 
structure. (A) Tetradentate nitrilotriacetic acid (NTA) binds to Ni2+ with three 
carboxyl groups and one nitrogen. (B) Ni-NTA column is one common method to 
purify his-tagged proteins, of which one Ni-NTA group can bind with two histidine. 
(C) NTA group can form coordination complex with nanogold. (D) Structure of NTA 
side chain that coordinate with gold in (C). Each aromatic ring has the same side 
chain as in (D), which abbreviated as tilde. (Hainfeld et al., 1999) 
 
Ni2+ capable of six binding sites can form tetradentate coordination complex with 
nitrilotriacetic acid (NTA), where three carboxyl groups and one nitrogen of NTA 
binds to one Ni2+ (Figure 4-1A). The leftover two sites of Ni-NTA can bind with two 
nitrogen of imidazole ring of histidine (Figure 4-1B), and a string of six histidine was 
found to produce a strong and specific bonding to Ni2+ when it was held by NTA. It 
has made great success in using immobilized Ni-NTA (Ni-NTA column) to purify 
many proteins with inserted his-tag at their N or C terminus. The dissociation constant 
(Kd) of his-tagged proteins to Ni-NTA has been measured to be 10
-13 at pH 8 (Schmitt 
et al., 1993). Such binding is much stronger than most antibody bindings, which 
typically range from 10-6 to 10-9 (Harlow and Lane, 1988). Hainfeld et al. (1999) 
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synthesized Ni-NTA-Au nanoparticles, of which Ni-NTA was attached to Au surface 
merely through a 13-carbon chain (Figure 4-1D). Thus, if his-tag was inserted to N or 
C terminal of sbGLuc, where sbGLuc was tethered outside of cell membrane through 
VChR1 of eLMO3, AuNP should be able to attach to sbGLuc with great proximity 
(Figure 4-2), which could enhance bioluminescence through LSPR on AuNP surface. 
 
 
Figure 4-2 Schematic representation of Ni-NTA-Au binding with Nhis_GLuc(LMO). 
VChR1 is a transmembrane protein, of which extracellular N terminal end fused with 
sbGLuc, and intracellular C terminal end fused with EYFP as a reporter gene. In this 
case, his-tag was inserted at the N terminal of sbGLuc, which can conjugate with Ni-
NTA-Au. The other two version of his-tagged GLuc(LMO) should bind with Ni-





4.2.1 Plasmid Design 
 
Figure 4-3 Schematic sequence structure of the original eLMO3 (GLuc(LMO)) and 
designed three his-tagged eLMO3. Nhis_GLuc(LMO), where one his-tag tendom with 
rTEV site was inserted at N terminal of sbGLuc part. NChis_GLuc(LMO), where 
besides one his-tag at N terminal, another his-tag was inserted into the linker between 
sbGLuc and VChR1. Chis_GLuc(LMO), where one his-tag was inserted into the 
linker between sbGLuc and VChR1. 
 
The eLMO3 coding plasmid, pcDNA3.1/sbGLuc-VChR1-EYFP, was already made in 
our lab’s previous work (Zhang et al., (In preparation)). In this study, his-tag tandem 
with rTEV site (recombinant tobacco etch virus protease recognition site) was first 
inserted into N terminal of LMO3 by QuikChange II Site-Directed Mutagenesis Kit 
(Agilent, USA). Then, another his-tag was inserted to the linker of sbGLuc and 
VChR1 in the same way. Thus, we generated three versions of six his-tagged LMO3 
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proteins, which have N terminal his-tagged sbGLuc of LMO3, both N and C terminal 
his-tagged sbGLuc of LMO3, and C terminal his-tagged sbGLuc of LMO3. We 
named them as Nhis_GLuc(LMO), NChis_GLuc(LMO) and Chis_GLuc(LMO), 
respectively (Figure 4-3). The forward primers used in QuikChange II kit was shown 
in Table 4, where its complementary sequences were reverse primer. Since the 
explicit structure of GLuc is still unknown, we believed such permutation of his-tag 
could maximize the chance of the exposure of his-tag to Ni-NTA-Au. 
 
Table 4 Primers Used in QuikChange 
His-tag Insertion Place Forward Primer 
N terminus of sbGLuc TCGAGCCACCATGGTGCATCATCACCATCACCATG
AGAACCTGTACTTCCAGGGCG 
C terminus of sbGLuc CTAGTCCATCACCACCACCATCACA 
 
4.2.2 In vitro AuNP bioluminescence enhancement 
HEK293 cells were maintained in Dulbecco’s Modified Eagle Medium, high glucose 
with phenol red (DMEM, sigma) and supplemented with 10% (V/V) fetal bovine 
serum (Atlanta Biologicals, USA) and 1% (V/V) penicillin-streptomycin (P/S, Sigma) 
under 37 °C and 5% CO2. Ni-NTA-Au with diameter of 1.8, 5, and 10 nm, was 
purchased directly from the company (Nanoprobes, USA), of which the concentration 
is 10 μΜ, 500 nM, and 50 nM, respectively. As a control, we also purchased 5 and 10 
nm simple gold nanoparticle (simple Au) stabilized in 0.1 mM PBS from the 
company (Sigma, USA), of which the concentration is 100 and 10 nM, respectively. 
First, we examined the effect of AuNP size on bioluminescence enhancement. After 
HEK293 cells were plated into a 96-well white plate with clear flat bottom (ref# 
655098, Greiner Bio-One), the cells were transfected with GLuc(LMO), 
Nhis_GLuc(LMO), NChis_GLuc(LMO), and NC_GLuc(LMO) using lipofection at 
proper cell confluency. On the next day after the transfection, the medium of the cells 
expressing each kind of the LMO proteins was replaced with DPBS (Sigma, USA) 
diluted with 500 pΜ of one of AuNPs described above (3 sizes of Ni-NTA-Au, 2 
sizes of simple Au, and the same volume of 10 nm Ni-NTA-Au buffer), then 
incubated in the cell incubator (37 °C, 5% CO2) for 15 mins. Then, the cells were 
carefully washed by replacing the medium with DPBS once. Finally, DMEM with 15 
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μΜ coelenterazine (NanoLight, USA) was added into each well, and relative 
luminescence intensity (RLU) of each well was measured by the plate reader (FLUO 
star OPTIMA, BMG Labtech, Germany). Second, we examined the effect of different 
concentration of 10 nm AuNP on bioluminescence enhancement. Cells were prepared 
and transfected in a 96-well white plate as same as the first experiment. On the next 
day after the transfection, the medium of the cells expressing the different LMO 
proteins was replaced with DPBS diluted with 0.5, 1, and 5 nM 10 nm Ni-NTA-Au; 
and 5 nM 10 nm simple Au stabilized in citrate buffer (Sigma, USA). Since we 
observed in the previous experiment that the 10 nm simple Au stabilized in 0.1 mM 
PBS will aggregate after diluted in DPBS, here we replaced it with the same size 
simple Au stabilized in citrate buffer, which is stable in DPBS. After incubating in the 
CO2 incubator (37 °C, 5% CO2) for 15 mins, the cells were carefully washed by 
replacing the medium with DPBS once. Finally, DMEM with 15 μΜ coelenterazine 
(NanoLight, USA) was added into each well, and relative luminescence intensity 
(RLU) of each well was measured by the plate reader (FLUO star OPTIMA, BMG 
Labtech, Germany). The relative luminescence unit (RLU) data were analyzed by 
using RStudio program.  
We also examined the expression of all four versions of the proteins by western blot 
and fluorescence imaging. For western blot, a new batch of HEK293 cells was plated 
in a 6-well culture plate (Company) and transfected with the four GLuc(LMO)s as 
mentioned above. The cells were lysed by adding 1 ml RIPA buffer (Thermo 
Scientific, USA) in each well by following the manufacturer’s instructions. The 
protein concentration was then determined by Bradford assay (Bio-Rad, USA), and 20 
μg total protein of each sample was run in 4%-6% sodium dodecyl sulfate bis-
acrylamide (SDS-PAGE) electrophoresis gel (Bio-Rad, USA). The protein in the gel 
was subsequently transferred onto a polyvinylidene difluoride (PVDF) membrane 
(Immobilon-P; Millipore). The blot was incubated in the primary antibody: rabbit 
polyclonal anti-GFP antibody (Code No: 598; 1:2,000 dilution; MBL International, 
MA). β-tubulin was used as a positive control to confirm the protein was extracted 
successfully and to confirm equal protein quantity loading. The secondary antibody 
was goat anti-rabbit IgG (heavy and light chains) conjugated with a fluorescent dye, 
Dylight® 680 (1:10,000 dilution; Thermo Scientific, USA). The blotted membrane 
was imaged by Odyssey scanner (LI-COR, USA). Fluorescence images of the cells 
used in in vitro AuNP incubation were captured by a Leica DM IRE2 inverted 
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microscope (Leica, Germany) equipped with a Leica CTR MIC controller and a 
RetigaEX camera (QImaging, Canada). Imaging setup was optimized for individual 
wells to suit for representation. 
4.3 Results and Discussion 
4.3.1 Structure of his-tagged GLuc(LMO) 
We designed three his-tagged GLuc(LMO) fusion proteins based on luminopsin 
eLMO3 (Zhang, In preparation), which is mainly composed of sbGLuc, VChR1 and 
EYFP from N to C terminus (Figure 4-3). His-tag was inserted to the N terminus, C 
terminus, or both in sbGLuc of eLMO3, which located outside of cell membrane after 
expression. Since the explicit structure of GLuc is still unknown, such permutation 
could maximize the chance of the exposure of his-tag to Ni-NTA-Au. It has been 
shown that Ni-NTA-Au can specifically bind with purified his-tagged adenovirus 
knob protein in vitro (Hainfeld et al., 1999). Meanwhile, Ni-NTA was synthesized 
with Au surface merely through a 13-carbon chain (Figure 4-1D), thus such proximity 
between Au surface and sbGLuc could facilitate scattering instead of absorption of 
bioluminescence (the latter will quench bioluminescence). 
4.3.2 In vitro Ni-NTA-Au Bioluminescence Enhancement in HEK293 cells 
The successful expression of four GLuc(LMO)s were confirmed by both fluorescence 
imaging (Figure 4-4A) and western blot (Figure 4-4B). The results of western blot 
showed that NChis_GLuc(LMO) and Chis(LMO) have two band, the lower one is 
near the calculated size (84.4 kDa), and higher one is about twice bigger (~150 kDa). 
Crystallography of ChR2 (structurally close related with VChR1) found that ChR2 
can form stable dimmer in SDS (Muller, Bamann, Bamberg, & Kuhlbrandt, 2011). 
Thus, the double band implied that VChR1 could also form stable dimer in SDS. Also, 
compared with the band of unmodified GLuc(LMO), the band of Chis_GLuc(LMO) 
is thicker than N and NC version of GLuc(LMO). Since the same amount of total 
protein were loaded when running the western blot, it is certain that the expression 
levels of the four GLuc(LMO)s are different. Chis_GLuc(LMO) kept the similar 
expression level as GLuc(LMO), whereas Nhis_GLuc(LMO) and NChis_(LMO) have 
less expression products. This was also confirmed by microscopic observation of 
fluorescent HEK cells under the same condition (Figure 4-5). This was probably 
49 
 
caused by the interference of the his-tag (together with rTEV site) on the native 
secretion signal of sbGLuc, since the secretion signal was located at the N terminal of 
sbGLuc, which plays a critical role on surface trafficking of LMO (Zhang et al., 
submitted). 
 
Figure 4-4 Nhis_GLuc(LMO), NChis_GLuc(LMO), Chis_GLuc(LMO) and 
GLuc(LMO) expression in HEK293 cells. (A) Four GLuc(LMO)s are expressed on 
the membrane of the cell, of which the fluorescence emitted from the periphery of the 
cells. (B) Western blot results. The weaker lower band at 100 kDa is the monomeric 
portion of four GLuc(LMO), and the strong band at 150 kDa is the dimer.  
 
 
Figure 4-5 Total light yield of the four GLuc(LMO)s. RLU: relative luminescence 
unit. Error bars represent SEM. n = 8. 
 
Next, we investigated the AuNP size effect of both Ni-NTA-Au and simple Au on 
bioluminescence of four GLuc(LMO)s. Figure 4-6 showed the enhancement factor, 
which is the ratio of RLU incubated with AuNPs over RLU without AuNPs of the 
same plasmids, increased with escalating sizes of AuNPs for both Ni-NTA-Au and 
simple Au under the same concentration 0.5 nM. However, under the current 
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concentration, all three sizes of Ni-NTA-Au have negative effect (enhancement factor 
<1) on bioluminescence, whereas simple Au has bigger enhancement factor compared 
with the same sizes of Ni-NTA-Au, and 10 nm simple Au exhibited up to 15% 
increase of bioluminescence in NChis_GLuc(LMO) version or no decrease at least for 
the rest plasmids. This suggested that under current concentration, Ni-NTA coated 
AuNPs absorb more than scatter the lights from the luciferase, and simple Au without 
Ni-NTA have less such side effect, while increasing the size of AuNPs can reduce the 
unwanted absorption of the luciferase emission. Noticeably, GLuc(LMO) has similar 
trends in both Ni-NTA-Au and simple Au with other his-tagged GLuc(LMO)s 
plasmids. This suggested that simple Au behaves similarly with Ni-NTA-Au in 
interaction with luciferase and Ni-NTA coating doesn’t increase the specificity of Au-
luciferase interaction. It is also noticeable that after diluting the simple Au (stabilized 
in 0.1 mM PBS) into DPBS, the color of the simple Au changed from red to black 
suggesting the aggregation of Au due to high ionic strength, which was later confirm 
by the red shift of the absorption peak of the simple Au-DPBS solution (spectrum 
data not shown). Thus, the simple Au diameter in this experiment might be bigger 
than 10 nm. Still, the results suggested that increasing the size of AuNPs to 10 nm 
could potentially enhance bioluminescence instead of quenching the light. This 
observation was also consistent with the prediction of LSPR theory and experiments 
that bigger AuNPs size allows the wider absorption across-sections and the higher 
ratio of scattering to absorption (He, Liu, Kong, & Liu, 2005; Jain et al., 2006; Link 




Figure 4-6 Enhancement factor of Nhis_GLuc(LMO), NChis_GLuc(LMO), Chis_ 
GLuc(LMO) and GLuc(LMO), after incubating with 0.5 nM of various size of AuNPs. 
Enhancement factor = RLU incubated with AuNPs / RLU incubated with buffer only. 
Error bars represent SEM, and n = 8. 
 
Then, I investigated the enhancement effect of 10 nm diameter Ni-NTA-Au with 
increased concentration (0.5, 1, 5 nM) and 10 nm diameter simple Au with the 
concentration of 5 nM, which incubated with four GLuc(LMO)s expressed in 
HEK293 cells. The simple Au used here was stabilized in the citrate buffer instead of 
0.1 mM PBS, which does not aggregate after diluted in DMEM confirmed by the 
absorption spectrum of the simple Au-DPBS solution (data not shown). The RLU of 
each condition was first normalized based on their corresponding plasmid without Ni-
NTA-Au incubation to obtain the enhancement factors, which is the ratio of the RLU 
versus the mean RLU of the same plasmid without Ni-NTA-Au. A one-way ANOVA 
was conducted to the RLU at the various concentrations of Ni-NTA-Au. If any 
significance at the P<.05 level was detected, post hoc multi-comparison using Turkey 
HSD test was followed to indicate between which groups in the same plasmid are 
significant different at the P<.05 level. From Figure 4-7, the RLU of 
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Nhis_GLuc(LMO) and GLuc(LMO) incubated with 5 nM simple Au (d = 10 nm) 
exhibited 25% and 28% bioluminescence enhancement respectively compared with 
the same condition without adding AuNPs (F(4,35) =4.66, *P=0.004, n=8 in one-way 
ANOVA, and *P=0.027 between 0 and 5 nM simple Au in Turkey’s HSD test for 
Nhis_GLuc(LMO); F(4, 35)=4.33, *P=0.006, n=8 in one-way ANOVA, and 
*P=0.003 between 0 and 5 nM simple Au in Turkey’s HSD test for GLuc(LMO)).  
GLuc(LMO) also showed the elevated enhancement with the increasing concentration 
of Ni-NTA-Au concentration from 0.5 nM to 5 nM, whereas other his-tagged versions 
didn’t have similar trends. The results also turned out that Ni-NTA-Au with bigger 
size (10 nm) still cannot significantly enhance the bioluminescence, however, simple 
Au can significantly enhance the bioluminescence both in his-tagged 
Nhis_GLuc(LMO) and GLuc(LMO) without his-tag. It could possibly have two 
explanations: the Ni-NTA-Au doesn’t bind to the his-tagged proteins, or specific 
bound Ni-NTA-Au is not in the wrong position where the distance to the sbGLuc is 
prone to absorb but not enhance the bioluminescence. Meanwhile, the simple Au can  
bind with sbGLuc of GLuc(LMO)s through nonspecific binding of available “high 
Gibbs free energy” surface on AuNPs, since Au can spontaneously form Au-S 
covalent bonds with 5 cysteine residues in sbGLuc (Ackerson et al., 2006), which 
enables the LSPR between Au surface and sbGLuc. Abhijith et al. (2014) also showed 
that simply adding Au-Ag alloy nanoparticles to purified luciferase can enhance 
bioluminescence, which could be the results of Au-S interaction. Indeed, it is 
recommended for the further study to take electron microscopic picture of the cells by 
SEM to see where the AuNPs actually bind. Also, more theoretical analysis should be 
conducted to determine the optimum distances and sizes of AuNPs to the sbGLuc to 




Figure 4-7 Enhancement factors of Nhis_GLuc(LMO), NChis_GLuc(LMO), Chis_ 
GLuc(LMO) and GLuc(LMO), after incubating with 0.5, 1, 5 nM of Ni-NTA-Au and 
simple Au (both d = 10 nm). 5s is the concentration of 5 nM simple Au. Statistical 
significance was compared with RLU without Ni-NTA-Au (0 nM). Error bars 
represent SEM, n = 8. *P < 0.05 by one-way ANOVA and Turkey’s HSD test. 
  
4.3.3 Evaluation of the Performance 
Here, we proposed a simple strategy of leveraging histidine-Ni-NTA coordination 
complex and LMO proteins such that AuNP could be conjugated with sbGLuc on the 
cell membrane and enhance its bioluminescence. However, the results turned out that 
the Ni-NTA-Au at current sizes and binding position cannot enhance the 
bioluminescence, whereas plainly adding simple Au to the cell can enhance around 25 
to 28% bioluminescence of sbGLuc expressed on the cell membrane, which we 
thought could be caused by the nonspecific binding of simple Au on sbGLuc through 
Au-S interaction. Although our Ni-NTA-Au doesn’t function as expected, our results 
are the first to show that AuNPs can directly enhance bioluminescence on the cell 
surface, which expands the AuNP enhancement on the bioluminescence of some 
purified luciferase proteins (Abhijith, Sharma, Ranjan, & Thakur, 2014; Du et al., 
2014), However, there are still many shortcomings that can be improved for future 
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study. First, LSPR theoretically enables much stronger enhancement (Zhan, Zhang, 
Zhao, Liu, & He, 2015). It has already been shown that AuNPs conjugated with 
purified horseradish peroxidase (HRP) can exhibit near 10-fold enhancement (Du et 
al., 2014). It is still a challenge to design proper AuNP docking strategy when the 
native GLuc structure remains unknown. Thus, we believe after the unveiling of 
GLuc structure, the structure guided design of AuNP conjugation could greatly 
ameliorate the enhancement efficiency. Second, since AuNP surfaces are intrinsically 
active, nonspecific binding of AuNPs is another great challenge if it is implemented 
in vivo. Although in our study the simple Au exhibited greater enhancement than Ni-
NTA-Au, which I believe is caused by Au interaction with cysteine in sbGLuc, the 
enhancement by specific binding AuNPs is a major objective to achieve in the future. 
Currently, some in vivo applications of AuNPs will conjugate AuNP with targeted 
antibodies to reduce nonspecific binding (Montenegro et al., 2013). But, 
immunoglobin (IgG) binds with simple Au nonspecifically, and it requires specific 
epitope fused to the target proteins, which still needs to be tested for its enhancement 
performance. Third, further studies should be performed to examine whether the 
enhanced bioluminescence can improve activation of VChR1 in LMO. Due to the 
limitation of time, this part was not performed in this study, but it will be an important 
application of this study.  
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CHAPTER 5 CONCLUSION OF THE THESIS 
In the Chapter 3, I designed GCaMPGLuc and GLucGCaMP, which can work either 
as a bioluminescence resonance energy transfer (BRET)-based ratiometric Ca2+ 
indicator or as a fluorescence-based intentiometric Ca2+ indicator. When used as 
BRET-based Ca2+ indicators, binding of free Ca2+ on CaM of the GCaMP6s moiety 
will trigger conformational changes due to the Ca2+-CaM-M13 interaction, and induce 
a subsequent conformational change in cpEGFP, which ultimately determine the 
efficiency of BRET between sbGLuc and cpEGFP indicated by the ratio of the EGFP 
emission peak versus the sbGLuc emission peak. When used as fluorescence based 
Ca2+ indicators, their GCaMP6s part can function separately from sbGLuc and the 
cpEGFP moiety can be excited directly by external light resources. The two indicators 
were tested in HEK293 cells and the resulting emission was able to be fitted with the 
Hill equation to report their dynamic range, apparent Kd, effective Kd (corrected 
apparent Kd of the ratiometric GECIs to be comparable with the apparent Kd of 
GCaMP6s) and Hill coefficient. The effective Kd of GCaMPGLuc is 223.3 nM, which 
is close to the effective Kd of GLucGCaMP 165.5 nM and the apparent Kd of 
GCaMP6s 144 nM. Thus, fusing sbGLuc to GCaMP6s either N or C terminus doesn’t 
remarkable affect the overall Ca2+ affinities of GCaMP6s. The new designs conserve 
the sensitivity and accuracy of the original GCaMP6 and provide BRET-based 
ratiometric measurements of [Ca2+], thereby expanding the ability of GECIs in living 
cells where noninvasive detection is required. Future studies can test the Ca2+ binding 
kinetics and pKa of the indicators, improve the dynamic range, and further evaluate 
their in vivo performance. 
In Chapter 4, I designed three hexahistidine-tagged GLuc(LMO)s, which could 
ideally conjugate with Ni-NTA-Au nanoparticles on the cell surface with high 
specificity. Chis_GLuc(LMO) and GLuc(LMO) have higher expression level in 
HEK293 cells compared with Nhis_GLuc(LMO) and NChis_GLuc(LMO), 
suggesting that the insertion of his-tag at the N terminus could interfere with the 
normal cell processes of the native secretion signal of GLuc. After investigating the 
size and concentration of various Ni-NTA-Au and comparing with simple Au 
nanoparticles without Ni-NTA coating, it turned out that Nhis_GLuc(LMO) and 
GLuc(LMO) without his-tag incubated with 5 nM simple Au of 10 nm diameter 
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showed 25% and 28% bioluminescence enhancement compared with the same 
plasmid without adding AuNPs, respectively. However, Ni-NTA-Au failed to exhibit 
any significant enhancement in all four GLuc(LMO)s. The enhancement from the 
simple Au could be the results of nonspecific binding between the simple Au surfaces 
and sulfhydryl groups from 5 cysteines in sbGLuc. Still, this study proved that AuNPs 
can conjugate with luciferase to leverage LSPR of Au surface to enhance the 
bioluminescence intensity on the cell surfaces. Thus, AuNPs potentially could be used 
to improve luciferase dependent biosensors, which benefits from higher 
bioluminescence intensity. Future studies can improve specificity of AuNP binding 
such as capping with small molecules with sulfhydryl group to further block the free 
surface of AuNPs, improve efficient LSPR of AuNP with luciferase, and investigate 
spectral characteristics of AuNP enhanced bioluminescence and the enhancement 
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